Top

Ray Y. Hachem, M.D.

Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine

Present Title & Affiliation

Primary Appointment

Professor, Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Infectious Diseases Trainee and Observorship Program, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1986	University of Santiago, Santo Domingo, DO, MD
1983	The University of Texas, Austin, Texas, US, Chemical Engineering, (Minor: Biomedical Engineering),, BS
1980	Wharton Junior College, Wharton, Texas, US, Science, BA

Postgraduate Training

1980-1980

Research Assistant, Baylor College of Medicine, Houston, Texas

Experience & Service

Faculty Academic Appointments

Associate Professor, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014

Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2001 - 2008

Research Investigator, Department of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1998 - 2001

Postdoctoral Fellow, Department of Medical Specialties, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1988 - 1998

Administrative Appointments/Responsibilities

Member, Division of Internal Medicine Cancer Survivorship Grand Round Steering Committee, Houston, 2007 - Present

Chairman, Division of Internal Medicine Research Committee, Houston, 2007 - 2009

Member, Steering Committee for Sister Institution between The University of Texas MD Anderson Cancer Center and American University of Beirut, Houston, 2007 - Present

Member, Institutional Review Board, Houston, 2006 - Present

Member, Institutional Research Grant (IRG) Committee, Houston, 2005 - 2007

Member, Clinical Research Committee, Houston, 2003 - 2006

Member, Ad Hoc Committee of the Infection Control Subcommittee for the Prevention of Fungal Infections, Houston, 2003 - 2007

Other Professional Positions

IRB - Associate Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present

Member, Institutional Research Grant Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2008

Coordinator, ID/Leukemia Task Force for Collaborative Research, The University of Texas MD Anderson Cancer Center, Houston, 2005 - Present

Coordinator, ID/BMT Task Force for Collaborative Research, The University of Texas MD Anderson Cancer Center, Houston, 2004 - Present

Honors & Awards

2005	Fellow, Infection Disease Society of America
1981	AICHE
1980	Dean's High Honor List
1980	Golden Key National Honor Society
1980	Omega Chi Epsilon of Chemical Engineering
1980	Tau Beta Pi

Professional Memberships

American Lebanese Medical Association

2007 - Present

The Transplantation Society (Infectious Disease Society)

2000 - Present

Texas Infectious Disease Society

2000 - Present

Houston Infectious Disease Society

2000 - Present

Society of Healthcare Epidemiology of America

2000 - Present

Harris County Medical Society

2000 - Present

International Immunocompromised Host Society

1998 - Present

American Society for Microbiology

1998 - Present

Infectious Disease Society of America

1998 - Present

Selected Presentations & Talks

International Presentations

2010. The Changing Epidemiology and Controversies in the Diagnosis and Management of Invasive Candidiasis in Hematologic Malignancy Patients. Invited. Lebanese Society of Infectious Diseases. Beirut, LB.
2010. Advance in Medicine - Update on Fungal Infections. Invited. Worldwide Institute for Medical Education. Houston, US.
2010. Satellite Symposia: Pathology, Interventional Gastroenterology and Infectious Diseases. Invited. NAAMA 24th International Medical Convention. Beirut, LB.
2006. Diagnosis of Fungal Infections. Invited. 14th ICHS. Crans-Montana, CH.
2004. 13th International Immunocompromised Host Society Meeting. Invited. 13th International Immunocompromised Host Society Meeting. Granada, ES.
2004. Posaconazole as salvage therapy for Pseuallescheria infections: A case series. Invited. 14th European Congress of Clinical Microbiology and Infectious Diseases. Prague, CZ.
2003. Novel Antifungal Agents. Invited. Worldwide Institute of Medical Education at the General Organization of Teaching Hospitals. Cairo, EG.

Formal Peers

2013. Salvaging the CVC in the Setting of Bacteremia: The Role of Antimicrobial Lock Solutions. Invited. Sao Paulo, BR.
2013. Fungal Infections in Immunocompromised Patients. Invited. Beirut, LB.
2013. New Insights on Invasive Fungal Infections in Cancer Patients. Invited. Tokyo, JP.
2013. Challenges in the Management of Invasive Fungal Infections. Invited. Beirut, LB.

Less

Grant & Contract Support

Date:	2013 - 2015
Title:	A Multi-Centered, Randomized Open Label, Comparative Study to Assess the safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Blood Stream Infections due to Staphylococci
Funding Source:	Duke University/NIAID
Role:	Co-I
ID:	HHSN272200900023C

Date:	2012 - 2015
Title:	A Phase 3b Multi-Center, Double-blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomincin for Prophylaxis against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Funding Source:	Optimer Pharmaceuticals, Inc
Role:	Co-I
ID:	CS20120781-6200

Date:	2012 - 2013
Title:	Infections in Cancer Symposium
Funding Source:	AHRQ
Role:	Co-I
ID:	R13 HS021599-01

Date:	2012 - 2014
Title:	Open Label Study of Issavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Mold, Yeasts or Dimorphic Fungi
Funding Source:	Astellas Pharma Global Development, Inc
Role:	Co-I
ID:	CS2011-00034596

Date:	2010 - 2013
Title:	Open-label Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
Funding Source:	Theravance, Inc
Role:	Co-I
ID:	CS2010-00032796

Date:	2010 - 2012
Title:	Teleflex Medical Adherence of Biofilm to Gendine-Coated Teleflex Catheters
Funding Source:	Unknown
Role:	Collaborator

Date:	2008 - 2014
Title:	A Phase III double blind, randomized study to evaluate safety and efficacy of BAL8557 versus Voriconazole for primary treatment of invasive fungal disease caused by Aspergillus species or other filamentous fungi
Funding Source:	Astellas Pharma Global Development, Inc
Role:	Co-I
ID:	CS2007-00020157

Date:	2008
Title:	Methicillin-Resistant Staphylococcus Aureus Pneumonia in Cancer Patients: A 6 Year Experience at a Major Cancer Center
Funding Source:	Pfizer Pharmaceutical
Role:	Principal Investigator-MDACC
ID:	DR08-0299

Date:	2008
Title:	Safety of Linezolid in Bone Marrow Transplant Patients
Funding Source:	Pfizer Pharmaceutical
Role:	Principal Investigator-MDACC
ID:	RCR02-734

Date:	2006
Title:	Retrospective Chart Review to Evaluate the Hepatic Safety Profile of Concomitant Use of Caspofungin and Cyclosporin A
Funding Source:	Unknown
Role:	Principal Investigator-MDACC
ID:	CR02-635

Date:	2005 - 2008
Title:	Clinical Experience with Tigecycline in Cancer Patients
Funding Source:	Wyeth
Role:	Principal Investigator-MDACC
ID:	RCR06-0359

Date:	2003 - 2004
Title:	Novel Detection Method Performed on Serum for the Diagnosis of Invasive Fungal Infection in Cancer Patients
Funding Source:	Merck and Company
Role:	Principal Investigator-MDACC
ID:	LS2003-00009622

Date:	2003 - 2005
Title:	The Role of Aerosolyzed Agents in Combination with EDTA in Preventing Invasive Pulmonary Aspergillosis (IPA) in Murine Module
Funding Source:	Enzon, Inc
Role:	Principal Investigator-MDACC
ID:	LS2003-00009173LE

Title:	Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults and Adolescents
Funding Source:	Unknown
Role:	Collaborator

Title:	Caspofungin alone, voriconazole alone, and their combination in patients with invasive aspergillosis
Funding Source:	Unknown
Role:	PI
ID:	DR11-0129

Selected Publications

Peer-Reviewed Articles

Dagher, H, Hachem, RY, Hakim, C, Husni, R, Hammoudeh, DS, Karroum, MB, Hamerschlak, N, Assir, FF, Nasr, J, Rosenblatt, J, Jiang, Y, Wehbe, S, Zeenny, RM, Truong, YL, Chaftari, AP, Ghanem, O, Ibrahim, AE, Bizri, AR, Raad, II. A Prospective Randomised Clinical Study Comparing Polygalacturonic and Caprylic Acid Ointment to Medical-Grade Honey in the Management of Chronic Wounds. International Wound Journal 23(1), 2026. e-Pub 2026. PMID: 41574641.
Wehbe, S, Zakhour, R, Hachem, RY, Jiang, Y, Dagher, H, Salman, R, Chaftari, AP, Raad, II. Pediatric vs. Adult Invasive Aspergillosis in Cancer and Hematopoietic Transplant Patients. Journal of Fungi 11(11), 2025. e-Pub 2025. PMID: 41295152.
Haddad, AJ, Dib, RW, Chaftari, AP, Jiang, Y, Moussa, M, Dagher, H, Philip, A, Hachem, RY, Raad, II. Risk factors for catheter-related bloodstream infections in a high-risk cancer patient population. Infection Control and Hospital Epidemiology 46(7):692-695, 2025. e-Pub 2025. PMID: 40415573.
Wehbe, S, Chaftari, AP, Hachem, RY, Dagher, H, Haddad, AJ, Philip, A, Jiang, Y, Zakhour, R, Bakht, P, Shrestha, J, Lamie, PM, Sherchan, R, Makhoul, J, Chaftari, P, Raad, II. Prognostic Value of Serum and Bronchoalveolar Lavage Fluid Galactomannan Levels in Invasive Aspergillosis. Journal of Fungi 11(5), 2025. e-Pub 2025. PMID: 40422689.
Hachem, RY, Dagher, H, Chaftari, AP, Jiang, Y, Haddad, AJ, Wehbe, S, Shrestha, J, Sherchan, R, Lamie, PM, Makhoul, J, Chaftari, P, Raad, II. Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by Aspergillus terreus After the Introduction of Anti-Mold Azole Agents. Journal of Fungi 11(2), 2025. e-Pub 2025. PMID: 39997413.
Dagher, H, Chaftari, AP, Haddad, AJ, Jiang, Y, Shrestha, J, Sherchan, R, Lamie, PM, Makhoul, J, Chaftari, P, Hachem, RY, Raad, II. Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment. Journal of Fungi 11(2), 2025. e-Pub 2025. PMID: 39997454.
Dagher H, Chaftari A, Hachem R, Jiang Y, Philip A, Mulanovich P, Haddad A, Lamie P, Dib RW, John TM, Dailey Garnes NJM, Ali S, Chaftari P, Raad II. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel) 16(20), 2024. e-Pub 2024. PMID: 39456544.
Chaftari A, Dagher H, Hachem R, Jiang Y, Lamie P, Dib RW, John T, Haddad A, Philip A, Alii S, Mulanovich P, Yuan Y, Chaftari P, Raad I. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. Randomized Controlled Trial 79(10):2543-2553, 2024. e-Pub 2024. PMID: 39092963.
Gerges, B, Rosenblatt, J, Truong, YL, Jiang, Y, Shelburne, S, Chaftari, AP, Hachem, RY, Raad, II. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC-Antimicrobial Resistance 6(2), 2024. e-Pub 2024. PMID: 38601790.
Haddad, AJ, Hachem, RY, Moussa, M, Jiang, Y, Dagher, H, Chaftari, P, Chaftari, AP, Raad, II. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473412.
Gerges, B, Rosenblatt, J, Shellburne, SA, Chaftari, AP, Hachem, RY, Raad, II. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-Antimicrobial Resistance 5(6), 2023. e-Pub 2023. PMID: 38089460.
Dagher, H, Chaftari, AP, Subbiah, IM, Malek, A, Jiang, Y, Lamie, PM, Granwehr, BP, John, TM, Yepez Guevara, E, Borjan, J, Reyes-Gibby, CC, Flores, M, Khawaja, F, Pande, M, Ali, N, Rojo, R, Karp, DD, Chaftari, P, Hachem, RY, Raad, II. Long COVID in cancer patients. eLife 12, 2023. e-Pub 2023. PMID: 36748905.
Batista, MV, Ussetti, MP, Jiang, Y, Neofytos, D, Cortez, AC, Feriani, D, Schmidt Filho, J, França-Silva, IA, Raad, II, Hachem, RY. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities. Journal of Fungi 9(2), 2023. e-Pub 2023. PMID: 36836281.
Raad, II, Hachem, RY, Masayuki, N, Datoguia, TS, Dagher, H, Jiang, Y, Subbiah, V, Siddiqui, B, Bayle, A, Somer, RA, Fernández-Cruz, A, Gorak, E, Bhinder, A, Mori, N, Hamerschlak, N, Shelanski, S, Dragivich, T, Kiat, YV, Fakhreddine, S, Hanna, PA, Chemaly, RF, Mulanovich, VE, Adachi, JA, Borjan, J, Khawaja, F, Granwehr, BP, John, TM, Yepez Guevara, E, Torres, HA, Ammakkanavar, NR, Yibirin, M, Reyes-Gibby, CC, Pande, M, Ali, N, Rojo, RD, Ali, S, Deeba, R, Chaftari, P, Matsuo, T, Ishikawa, K, Hasegawa, R, Aguado-Noya, R, García, ÁG, Puchol, CT, Lee, DG, Slavin, MA, Teh, B, Arias, CA, Kontoyiannis, DP, Chaftari, AP. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer. eLife 12, 2023. e-Pub 2023. PMID: 36715684.
Dagher, H, Chaftari, AP, Mulanovich, P, Jiang, Y, Hachem, RY, Malek, A, Borjan, J, Viola, GM, Raad, II. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. eLife 11, 2022. e-Pub 2022. PMID: 36541589.
Chaftari AM, Hachem R, Malek AE, Mulanovich VE, Szvalb AD, Jiang Y, Yuan Y, Ali S, Deeba R, Chaftari P, Raad I. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis 9(6):ofac079, 2022. e-Pub 2022. PMID: 35663286.
Dagher H, Hachem R, Chaftari AM, Jiang Y, Ali S, Deeba R, Shah S, Raad I. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J Fungi (Basel) 8(1), 2022. e-Pub 2022. PMID: 35050014.
Chaftari P, Chaftari AM, Hachem R, Yeung SJ, Dagher H, Jiang Y, Malek AE, Dailey Garnes N, Mulanovich VE, Raad I. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med 10(23):8475-8482, 2021. e-Pub 2021. PMID: 34725958.
Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola GM, Raad II. Impact of Checkpoint Inhibitor Immunotherapy Primarily Pembrolizumab on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis 73(9):e2697-e2704, 2021. e-Pub 2021. PMID: 32564081.
Hachem R, Parikh UM, Reitzel R, Rosenblatt J, Kaul A, Vargas-Cruz N, Hill L, Moore L, Meyer J, Chaftari AM, Gagea M, Balaji S, Raad II. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair Regen 29(5):830-842, 2021. e-Pub 2021. PMID: 33956391.
Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJ. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439240.
Awadh H, Chaftari AM, Khalil M, Fares J, Jiang Y, Deeba R, Ali S, Hachem R, Raad II. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infect Dis 21(1):643, 2021. e-Pub 2021. PMID: 34225651.
Malek AE, Dagher H, Hachem R, Chaftari AM, Raad II. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors?. J Med Virol 93(7):4083-4084, 2021. e-Pub 2021. PMID: 33666244.
Melissa K, Anne-Marie C, Hiba D, Joel R, Ying J, Ruth A R, Ray Hachem, Hirsch-Ginsberg CF, Issam RI. Efficacy of a nitroglycerin-citrate-ethanol lock solution in maintaining central venous catheter patency and preventing thrombotic occlusions in cancer patients. Thromb Res 201:60-62, 2021. e-Pub 2021. PMID: 33639387.
Husni R, Chrabieh R, Dib RW, Vazquez J, Guimaraes T, Fernández A, Khoury R, Asmar L, Khazen G, Samaha N, Raad I, Hachem R. Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study. Mediterr J Hematol Infect Dis 13(1):e2021031, 2021. e-Pub 2021. PMID: 34007419.
Gerges BZ, Rosenblatt J, Truong YL, Reitzel RA, Hachem R, Raad II. Enhanced Biofilm Eradication and Reduced Cytotoxicity of a Novel Polygalacturonic and Caprylic Acid Wound Ointment Compared with Common Antiseptic Ointments. Biomed Res Int 2021:2710484, 2021. e-Pub 2021. PMID: 33708989.
Shelburne SA, Dib RW, Endres BT, Reitzel R, Li X, Kalia A, Sahasrabhojane P, Chaftari AM, Hachem R, Vargas-Cruz NS, Jiang Y, Garey K, Fowler VG, Holland TL, Gu J, Miller W, Sakurai A, Arias CA, Aitken SL, Greenberg DE, Kim J, Flores AR, Raad I. Whole-genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteraemia is caused by a limited number of closely related sequence types. Clin Microbiol Infect 26(5):646.e1-646.e8, 2020. e-Pub 2020. PMID: 31639470.
Abu-Sheih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi J, Hachem RY, Altan M, Jenq RR, Wang Y. Neutropenic Enterocolitis:Clinical Features and Outcomes. Dis Colon Rectum 63(3):381-388, 2020. e-Pub 2020. PMID: 31842164.
Dib RW, Khalil M, Fares J, Hachem RY, Jiang Y, Dandachi D, Chaftari AM, Raad II. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours. J Hosp Infect 104(3):358-364, 2020. e-Pub 2020. PMID: 31585141.
Sarkis R, Hassan H, Lichaa A, Hachem R. COVID-19 Pandemic in the midst of Lebanon worst financial crisis capital control or captain control?, 2020. e-Pub 2020.
Fares J, Khalil M, Chaftari AM, Hachem R, Jiang Y, Kantarjian HM, Raad II. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia. Open Forum Infect Dis 6(10):ofz357, 2019. e-Pub 2019. PMID: 31660336.
Chaftari AM, Viola GM, Rosenblatt J, Hachem R, Raad I. Advances in the Prevention and Management of Central Line Associated Bloodstream Infections: The Role of Chelator-Based Catheter Locks. Infect Control Hosp Epidemiol 40(9):1036-1045, 2019. e-Pub 2019. PMID: 31230604.
Vargas-Cruz N, Reitzel RA, Rosenblatt J, Chaftari AM, Wilson Dib R, Hachem R, Kontoyiannis DP, Raad II. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother 63(7), 2019. e-Pub 2019. PMID: 31036689.
Vargas-Cruz N, Rosenblatt J, Reitzel RA, Chaftari AM, Hachem R, Raad I. Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs). Biomed Res Int 2019:2869039, 2019. e-Pub 2019. PMID: 31976318.
Hachem R, Batista MV, Kanj SS, El Zein S, Haddad S, Jiang Y, Mori N, Vanderson R, Chaftari AM, Raad I. International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. Mediterr J Hematol Infect Dis 11(1):e2019003, 2019. e-Pub 2019. PMID: 30671209.
Wilson Dib R, Hachem R, Chaftari AM, Ghaly F, Jiang Y, Raad I. Treating Invasive Aspergillosis in patients with Hematologic Malignancy: Diagnostic -Driven Approach versus Empiric Therapies. BMC Infect Dis 18(1):656, 2018. e-Pub 2018. PMID: 3054320.
Wilson Dib R, Chaftari AM, Hachem RY, Yuan Y, Dandachi D, Raad II. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis 5(10):ofy249, 2018. e-Pub 2018. PMID: 30377625.
Raad II, Chaftari AM, Dib RW, Graviss EA, Hachem R. Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East. Infect Control Hosp Epidemiol 39(10):1230-1236, 2018. e-Pub 2018. PMID: 30099975.
Dandachi D, Wilson Dib R, Fernández-Cruz A, Jiang Y, Chaftari AM, Hachem R, Raad I. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med:1-8. e-Pub 2018. PMID: 30230385.
Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J, Sims M, Wray D, Zervos M, Fowler VG, Investigators SB. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. JAMA 320(12):1249-1258, 2018. e-Pub 2018. PMID: 30264119.
El Haddad H, Chaftari AM, Hachem R, Chaftari P, Raad II. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer. Clin Infect Dis 67(6):971-977, 2018. e-Pub 2018. PMID: 29668936.
Raad S, Chaftari AM, Hachem RY, Shah P, Natividad E, Cleeland CS, Rosenblatt J. Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden. Expert Rev Med Devices 15(8):591-596, 2018. e-Pub 2018. PMID: 30067125.
Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses. Clin Infect Dis 67(3):398-406, 2018. e-Pub 2018. PMID: 29546356.
Hachem R, Kanj S, Hamerschlak N, Saad H, Assir FF, Mori N, Jiang Y, Ghaly F, Chaftari AM, Raad II. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections. Expert Rev Med Devices 15(6):461-466, 2018. e-Pub 2018. PMID: 29927699.
Chaftari AM, Hachem R, Jiang Y, Shah P, Hussain A, Hamal ZA, Yousif A, Jordan M, Michael M, Raad I. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infect Control Hosp Epidemiol 39(6):727-729, 2018. e-Pub 2018. PMID: 29770754.
El Haddad H, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep 8(1):6258, 2018. e-Pub 2018. PMID: 29674672.
Chaftari AM, Hachem R, Raad S, Jiang Y, Natividad E, Chaftari P, Raad I. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol 39(2):222-225, 2018. e-Pub 2018. PMID: 29331162.
Haddad HE, Chaftari AM, Hachem R, Michael M, Jiang Y, Yousif A, Raad S, Jordan M, Chaftari P, Raad I. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep 8(1):1099, 2018. e-Pub 2018. PMID: 29348438.
Zakhour R, Hachem R, Alawami HM, Jiang Y, Michael M, Chaftari AM, Raad I. Comparing catheter-related bloodstream infections in pediatric and adult cancer patients. Pediatr Blood Cancer 64(10), 2017. e-Pub 2017. PMID: 28409898.
Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, Chaftari AM, Raad II. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents 50(3):384-388, 2017. e-Pub 2017. PMID: 28694233.
Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Amin S, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28743701.
Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Sapna A, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother 61(7), 2017. e-Pub 2017. PMID: 28416559.
Vargas-Cruz N, Reitzel RA, Rosenblatt J, Jamal M, Szvalb AD, Chaftari AM, Hachem R, Raad I. In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections. Antimicrob Agents Chemother 61(6), 2017. e-Pub 2017. PMID: 28320713.
Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control 45(3), 2017. e-Pub 2017. PMID: 28254252.
Hachem R, Reitzel R, Rolston K, Chaftari AM, Raad I. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother 61(4), 2017. e-Pub 2017. PMID: 28115350.
Hilal G, Reitzel R, Al Hamal Z, Chaftari AM, Al Wohoush I, Jiang Y, Hachem R, Raad II. Novel plasma telomerase detection method to improve cancer diagnostic assessment. PLoS One 12(5):e0174266, 2017. e-Pub 2017. PMID: 28467443.
Rosenblatt J, Reitzel RA, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm. Front Microbiol 8:1999, 2017. e-Pub 2017. PMID: 29093703.
Mahfouz N, Tahtouh R, Alaaeddine N, El Hajj J, Sarkis R, Hachem R, Raad I, Hilal G. Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors. PLoS One 12(6):e0179202, 2017. e-Pub 2017. PMID: 28594907.
Yousif A, Chaftari AM, Michael M, Jordan M, Al Hamal Z, Hussain A, Elizabeth N, Jiang Y, Hachem R, Raad I. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. Am J Infect Control 44(9):1037-40, 2016. e-Pub 2016. PMID: 26897695.
Chaftari AM, Jordan M, Hachem R, Al Hamal Z, Jiang Y, Yousif A, Garoge K, Deshmukh P, Raad I. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury. Am J Infect Control 44(8):931-4, 2016. e-Pub 2016. PMID: 27112370.
Reitzel RA, Rosenblatt J, Hirsh-Ginsberg C, Murray K, Chaftari AM, Hachem R, Raad I. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother 60(9):5175-81, 2016. e-Pub 2016. PMID: 27297475.
Raad I, Chaftari AM, Zakhour R, Jordan M, Al Hamal Z, Jiang Y, Yousif A, Garoge K, Mulanovich V, Viola GM, Kanj S, Pravinkumar E, Rosenblatt J, Hachem R. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother 60(6):3426-32, 2016. e-Pub 2016. PMID: 27001822.
Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari AM, Raad II. Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism. Medicine (Baltimore) 95(14):e2691, 2016. e-Pub 2016. PMID: 27057825.
Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwehr B, Mulanovich V, Gagel A, Reitzel R, Yousif A, Jiang Y, Raad I. Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer: A Case Control Study. Antimicrob Agents Chemother. e-Pub 2015. PMID: 26482312.
Jamal MA, Hachem RY, Rosenblatt J, McArthur MJ, Felix E, Jiang Y, Tailor RC, Raad I. In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters. Antimicrob Agents Chemother 59(9):5611-8, 2015. e-Pub 2015. PMID: 26124171.
Chaftari AM, Hachem R, Reitzel R, Jordan M, Jiang Y, Yousif A, Garoge K, Deshmukh P, Al Hamal Z, Jabbour J, Hanania A, Raad S, Jamal M, Raad I. Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS One 10(7):e0130999, 2015. e-Pub 2015. PMID: 26148092.
Perfect JR, Hachem R, Wingard JR. Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis 59 Suppl 5:S352-5, 2014. e-Pub 2014. PMID: 25352630.
Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. e-Pub 2014. PMID: 25455847.
Debiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, Chaftari AM, Jabbour J, Al Shuaibi M, Hanania A, Pravinkumar SE, Schuetz P, Raad I. The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically Ill Patients With Cancer. Crit Care Med. e-Pub 2014. PMID: 25083975.
Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, Ramos E, Jiang Y, Chaftari AM, Raad II. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother. e-Pub 2014. PMID: 25006241.
El Zakhem A, Chaftari AM, Bahu R, El Helou G, Shelburne S, Jiang Y, Hachem R, Raad I. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. e-Pub 2014. PMID: 24491173.
Reitzel R, Rosenblatt J, Jiang Y, Hachem R, Raad I. Disposable gendine antimicrobial gloves for preventing transmission of pathogens in health care settings. Am J Infect Control 42(1):55-9, 2014. e-Pub 2014. PMID: 24388469.
Rosenblatt J, Reitzel R, Jiang Y, Hachem R, Raad I. Insights on the role of antimicrobial cuffed endotracheal tubes in preventing transtracheal transmission of VAP pathogens from an in vitro model of microaspiration and microbial proliferation. Biomed Res Int 2014:120468, 2014. e-Pub 2014. PMID: 24818125.
Chaftari AM, El Zakhem A, Jamal MA, Jiang Y, Hachem R, Raad I. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis 14(1):518, 2014. e-Pub 2014. PMID: 25253042.
Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II. Prevention of Gram-Negative Bacterial Biofilm on Minocycline/Rifampin impregnated catheters sequentially coated with Chlorhexidine. Antimicrob Agents Chemother. e-Pub 2013. PMID: 24165191.
Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob Agents Chemother 57(8):3555-60, 2013. e-Pub 2013. PMID: 23669393.
Shomali W, Hachem R, Chaftari AM, Bahu R, Helou GE, Jiang Y, Hanania A, Reitzel R, Raad I. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?. Diagn Microbiol Infect Dis 76(2):158-61, 2013. e-Pub 2013. PMID: 23578976.
Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol. e-Pub 2013. PMID: 23519997.
El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, Tarrand J, Raad II. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis 56(6):843-6, 2013. e-Pub 2013. PMID: 23254418.
Uthamanthil RK, Hachem RY, Gagea M, Reitzel RA, Borne AT, Tinkey PT. Urinary catheterization of male rabbits: a new technique and a review of urogenital anatomy. J Am Assoc Lab Anim Sci 52(2):180-5, 2013. e-Pub 2013. PMID: 23562102.
El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13(2):166-74, 2013. e-Pub 2013. PMID: 23347634.
Bahu R, Chaftari AM, Hachem RY, Ahrar K, Shomali W, El Zakhem A, Jiang Y, AlShuaibi M, Raad II. Nephrostomy Tube Related Pyelonephritis in Patients with Cancer: Epidemiology, Infection Rate and Risk Factors. J Urol 189(1):130-5, 2013. e-Pub 2013. PMID: 23164390.
Raad I, Rosenblatt J, Reitzel R, Jiang Y, Dvorak T, Hachem R. Chelator-Based Catheter Lock Solutions in Eradicating Organisms in Biofilm. Antimicrob Agents Chemother 57(1):586-8, 2013. e-Pub 2013. PMID: 23070163.
Chaftari AM, Hachem RY, Ramos E, Kassis C, Campo M, Jiang Y, Prince RA, Wang W, Raad II. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation 94(3):302-8, 2012. e-Pub 2012. PMID: 22814329.
Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center. Oncologist. e-Pub 2012. PMID: 22707509.
Al Akhrass F, Al Wohoush I, Chaftari AM, Reitzel R, Jiang Y, Ghannoum M, Tarrand J, Hachem R, Raad I. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One 7(3):e32945, 2012. e-Pub 2012. PMID: 22427914.
Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. Improved Antibiotic Impregnated Catheters with Extended Spectrum Activity Against Resistant Bacteria and Fungi. Antimicrob Agents Chemother. e-Pub 2011. PMID: 22123686.
Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect 17(11):1711-6, 2011. e-Pub 2011. PMID: 21595787.
Campo M, Hachem R, Jiang Y, Dvorak T, Carrillo-Marquez M, Hulten K, Chemaly RF, Raad I. Panton valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant staphylococcus aureus (MRSA) infections. Medicine (Baltimore) 90(5):312-8, 2011. e-Pub 2011. PMID: 21862937.
Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad I. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 17(9):1651-8, 2011. e-Pub 2011. PMID: 21888790.
Lee LD, Hachem RY, Berkheiser M, Hackett B, Jiang Y, Raad II. Hospital environment and invasive aspergillosis in patients with hematologic malignancy. Am J Infect Control. e-Pub 2011. PMID: 21856045.
Raad II, Mohamed JA, Reitzel RA, Jiang Y, Dvorak TL, Ghannoum MA, Hachem RY, Chaftari AM. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes. Biomaterials 32(11):2689-2694, 2011. e-Pub 2011. PMID: 19805562.
Kassis C, Hachem R, Raad II, Perego CA, Dvorak T, Hulten KG, Frenzel E, Thomas G, Chemaly RF. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control 39(2):112-7, 2011. e-Pub 2011. PMID: 20817317.
Kassis C, Hachem R, Raad II, Perego CA, Dvorak T, Hulten KG, Frenzel E, Thomas G, Chemaly RF. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control 39(2):112-7, 2011. e-Pub 2011. PMID: 20817317.
Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad I. Central line associated Nocardia bcteremia in cancer patients. Emerging Infectious Diseases 17(9):1651-1658, 2011. e-Pub 2011.
Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 16(7):1049-60, 2011. e-Pub 2011. PMID: 21659609.
Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. e-Pub 2010.
Al Wohoush I, Cairo J, Rangaraj G, Granwehr B, Hachem R, Raad I. Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol 31(10):1089-91, 2010. e-Pub 2010. PMID: 20807036.
Al Wohoush I, Rivera J, Cairo J, Hachem R, Raad I. Comparing Clinical and Microbiological Methods for the Diagnosis of True Bacteremia among Patients with Multiple Blood Cultures Positive for Coagulase-Negative Staphylococci. Clin Microbiol Infect. e-Pub 2010. PMID: 20854425.
Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF. Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab. Biol Blood Marrow Transplant 16(9):1265-71, 2010. e-Pub 2010. PMID: 20304082.
Hogan HL, Hachem RY, Neuhauser M, Raad II, Coyle E. Clinical experience of linezolid n bone marrow transplant patients. Journal of Pharmacy Practice 23(4):352-357, 2010. e-Pub 2010.
Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967-73, 2010. e-Pub 2010. PMID: 20052728.
Ghide S, Jiang Y, Hachem R, Chaftari AM, Raad I. Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered?. Eur J Clin Microbiol Infect Dis 29(2):153-6, 2010. e-Pub 2010. PMID: 20016995.
Mihu CN, Kassis C, Ramos ER, Jiang Y, Hachem RY, Raad II. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?. Cancer 116:5290-5296, 2010. e-Pub 2010. PMID: 20665889.
Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Serverino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. Eur J Clin Microbiol Infect Dis 29(11):1387-1394, 2010. e-Pub 2010.
Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis 14(7):e548-552, 2010. e-Pub 2010. PMID: 20005762.
Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Waked A, Graviss L, Bekele BN, Shah JN, Raad II. Erratum to: Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case-Control Study. Ann Surg Oncol 17:1499-1506, 2010. e-Pub 2010. PMID: 20224857.
Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical Effectiveness and Risk of Emerging Resistance Associated with Prolonged Use of Antibiotic-Impregnated Catheters: More than 0.5 Million Catheter Days and 7 Years of Clinical Experience. Critical Care Medicine 39(2):245-251, 2010. e-Pub 2010.
Chemaly RF, Hachem RY, Rn H, Bahna B, Rjaili GA, Waked A, Graviss L, Nebiyou Bekele B, Shah JN, Raad II. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol 17(6):1499-1506, 2010. e-Pub 2010.
Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore) 89(4):236-244, 2010. e-Pub 2010.
Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 53(12):5145-9, 2009. e-Pub 2009. PMID: 19805562.
Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 37(9):741-5, 2009. e-Pub 2009. PMID: 19487050.
Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115(20):4745-52, 2009. e-Pub 2009. PMID: 19634156.
Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?. Clin Infect Dis 49(8):1187-94, 2009. e-Pub 2009. PMID: 19780661.
Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I. Differentiating Coagulase-Negative Staphylococcal Bacteremia from Contamination Using Time to Positivity and Quantitative Blood Cultures Methods. J Clin Microbiol 47(10):3255-60, 2009. e-Pub 2009. PMID: 19692564.
Kassar R, Hachem R, Jiang Y, Chaftari AM, Raad I. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore) 88(5):279-283, 2009. e-Pub 2009. PMID: 19745686.
Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control 37(6):442-6, 2009. e-Pub 2009. PMID: 19118923.
Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore) 88(4):211-20, 2009. e-Pub 2009. PMID: 19593226.
Reitzel RA, Dvorak TL, Hachem RY, Fang X, Jiang Y, Raad I. Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. Am J Infect Control 37(4):294-300, 2009. e-Pub 2009. PMID: 19155100.
Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47(1):129-33, 2009. e-Pub 2009. PMID: 19005145.
Ramos ER, Hachem R, Youssef S, Fang X, Jiang Y, Raad I. The crucial role of catheters in micrococcal bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 30(1):83-5, 2009. e-Pub 2009. PMID: 19046050.
Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sherertz RJ, Kontoyiannis DP. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 32(6):515-8, 2008. e-Pub 2008. PMID: 18783924.
Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control 36(9):656-60, 2008. e-Pub 2008. PMID: 18834742.
Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X, Shuikrallah B, Raad II. Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer. Infection. e-Pub 2008.
Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer 112(6):1282-7, 2008. e-Pub 2008. PMID: 18224662.
Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica 93(1):157-8, 2008. e-Pub 2008. PMID: 18166808.
Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B Lipid Complex (ABLC) vs. Liposomal Amphotericin B (L-AMB) Monotherapy of Invasive Aspergillosis (IA) in Patients with Hematological Malignancy (HM). Cancer 112(6):1282-7, 2008. e-Pub 2008.
Hachem R, Langston A, Graybill J, Perfect J, Pedicone L, Patino H, Raad I. Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment. J Antimicrob Chemo, 2008. e-Pub 2008.
Raad II, Hanna HA, Boktour M, Jiang Y, Torres H, Afif C, Kontoyiannis DP, Hachem RY. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: Posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22(3):496-503, 2008. e-Pub 2008.
Youssef S, Hachem R, Chemaly RF, Adachi J, Ying J, Rolston K, Raad I. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother 61(2):421-4, 2008. e-Pub 2008. PMID: 18174198.
Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. The Changing Epidemiology of Invasive Candidiasis: Candida glabrata and Candida krusei As the Leading Causes of Candidemia in Hematologic Malignancy. Cancer 112(11):2493-9, 2008. e-Pub 2008. PMID: 18412153.
Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 28(9):1054-1059, 2007. e-Pub 2007. PMID: 17932826.
Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and outcomes of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 26(8):549-56, 2007. e-Pub 2007. PMID: 17582536.
Shukrallah B, Hanna H, Hachem R, Ghannam D, Chatzinikolaou, Raad I. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis 58(4):453-457, 2007. e-Pub 2007. PMID: 17509805.
Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad I. Colistin is effective in the treatment of multidrug-resistant Pseudomonas aeruginosa infections in cancer patients. Antimicrob Agents Chemother 51:1905-11, 2007. e-Pub 2007.
Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sheretz R, Hachem R. Comparative Activity of Daptomycin, Linezolid and Tigecycline Against Catheter-Related Methicillin-resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm. Antimicrob Agents Chemother 51:1656-60, 2007. e-Pub 2007.
Bahna P, Hanna H, Dvorak T, Hachem R, Raad I. Antiseptic effect of novel alcohol-free mouthwash: a convenient prophylactic alternative for high-risk patients. Oral Oncol 43:159-64, 2007. e-Pub 2007.
Bahna P, Dvorak T, Hanna H, Yasko AW, Hachem R, Raad I. Orthopaedic metal devices coated with a novel antiseptic dye for the prevention of bacterial infections. Int J Antimicrob Agents, 2007. e-Pub 2007. PMID: 17317111.
Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51:78-83, 2007. e-Pub 2007. PMID: 17074799.
Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) 86(1):54-60, 2007. e-Pub 2007. PMID: 17220756.
Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 44:2-12, 2007. e-Pub 2007. PMID: 17143808.
Keutgen XM, Hachem RY, Jiang Y, Pham-Williams T, Tarrand JJ, Raad II. A Comparison of Galactomannan-ELISA and a Newly Developed Galactomannan-LATEX Test in the Serologic Diagnosis of Invasive Aspergillosis in Patients with Hematologic Malignancies. Eur J Clin Microbiol Infect Dis, 2007. e-Pub 2007.
Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 2109:2615-2622, 2007. e-Pub 2007.
Lee L, Berkheiser M, Jiang Y, Hackett B, Hachem RY, Chemaly RF, Raad II. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol 28:1066-1070, 2007. e-Pub 2007.
Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, Raad I. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother 50:3283-8, 2006. e-Pub 2006. PMID: 17005806.
Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 174:461-70, 2006. e-Pub 2006. PMID: 16728708.
Hachem R, Sumoza D, Hanna H, Girgawy E, Munsell M, Raad I. Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised?. Cancer 106(7):1581-6, 2006. e-Pub 2006. PMID: 16475153.
Ullman JA, Cornely AO, Burchardt A, Hachem R, Kontoyiannis DP, Topelt K, Courtney R, Wexler D, Krishna G, Martinho M, Corcoran G, Raad II. Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or with refractory invasive fungal infection. Antimicrob Agents Chemother 50:658-666, 2006. e-Pub 2006.
Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as Salvage Therapy for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions. Clin Infect Dis 42:1398-1403, 2006. e-Pub 2006.
Boktour M, Hanna H, Ansari S, Bahna P, Hachem R, Tarrand J, Rolston K, Safdar A, Raad I. The central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106:1967-1973, 2006. e-Pub 2006.
Hachem R, Bahna P, Hanna H, Stephens LC, Raad I. EDTA as an Adjunct Antifungal Agent for Invasive Pulmonary Aspergillosis in a rodent model. Antimicrob Agents Chemother 50:1823-1827, 2006. e-Pub 2006.
Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104(6):1213-20, 2005. e-Pub 2005. PMID: 16078263.
Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, Dvorak T, Hogan H, Hachem R, Rolston K, Raad I. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104(1):205-12, 2005. e-Pub 2005. PMID: 15880433.
Raad, II, Hanna HA, Boktour M, Jabbour N, Hachem RY, Darouiche RO. Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 26(7):658-61, 2005. e-Pub 2005. PMID: 16092749.
Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103(11):2334-7, 2005. e-Pub 2005. PMID: 15844093.
Raad I, Darouiche R, Vazquez J, Lentnek A, Hachem R, Hanna H, Goldstein B, Henkel T, Seltzer E. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 40(3):374-80, 2005. e-Pub 2005. PMID: 15668859.
Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5:775-785, 2005. e-Pub 2005.
Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad II. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 101(12):2859-65, 2004. e-Pub 2004. PMID: 15529309.
Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer 101(10):2300-2, 2004. e-Pub 2004. PMID: 15452832.
Chatzinikolaou I, Hanna H, Hachem R, Alakech B, Tarrand J, Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 50(3):167-72, 2004. e-Pub 2004. PMID: 15541601.
Boktour MR, Kontoyiannis DP, Hanna HA, Hachem RY, Girgawy E, Bodey GP, Raad II. Multiple-species candidemia in patients with cancer. Cancer 101(8):1860-5, 2004. e-Pub 2004. PMID: 15386338.
Hachem RY, Kontoyiannis DP, Boktour MR, Afif C, Cooksley C, Bodey GP, Chatzinikolaou I, Perego C, Kantarjian HM, Raad II. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101(7):1594-600, 2004. e-Pub 2004. PMID: 15378491.
Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, Rice LB. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 48(9):3583-5, 2004. e-Pub 2004. PMID: 15328133.
Marr KA, Hachem R, Papanicolaou G, Somani J, Arduino JM, Lipka CJ, Ngai AL, Kartsonis N, Chodakewitz J, Sable C. Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A. Transpl Infect Dis 6(3):110-6, 2004. e-Pub 2004. PMID: 15569226.
Hanna H, Afif C, Alakech B, Boktour M, Tarrand J, Hachem R, Raad I. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 25(8):646-9, 2004. e-Pub 2004. PMID: 15357155.
Raad I, Hachem R, Hanna H. Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction. J Antimicrob Chemother 53(6):1105-8, 2004. e-Pub 2004. PMID: 15128724.
Hachem R, Graviss L, Hanna H, Arbuckle R, Dvorak T, Hackett B, Gonzalez V, Perego C, Tarrand J, Raad I. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 25(5):391-4, 2004. e-Pub 2004. PMID: 15188844.
Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother 53(4):646-9, 2004. e-Pub 2004. PMID: 14998986.
Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GP. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38(8):1119-27, 2004. e-Pub 2004. PMID: 15095217.
Kontoyiannis DP, Bodey GP, Hanna H, Hachem R, Boktour M, Girgaway E, Mardani M, Raad II. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma 45(1):139-41, 2004. e-Pub 2004. PMID: 15061210.
Kontoyiannis, DP, Hanna H, Hachem R, Boktour M, Girgawy E, Mardani M, Bodey G, Raad I. Risk factors of poor outcome of fusariosis in a tertiary care cancer center. Leuk/ Lymphoma 45:141-143, 2004. e-Pub 2004.
Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36(8):564-9, 2004. e-Pub 2004. PMID: 15370667.
Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47(11):3580-5, 2003. e-Pub 2003. PMID: 14576121.
Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer 98(5):1039-47, 2003. e-Pub 2003. PMID: 12942573.
Hachem RY, Hicks K, Huen A, Raad I. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis 37(1):e8-11, 2003. e-Pub 2003. PMID: 12830431.
Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 98(2):292-9, 2003. e-Pub 2003. PMID: 12872348.
Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 46(1):25-8, 2003. e-Pub 2003. PMID: 12742315.
Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R, Hachem R, Raad I. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36(1):116-9, 2003. e-Pub 2003. PMID: 12491212.
Hadi U, Bitar M, Hachem R, Saade R, Husni R, Raad I. Fungal sinusitis in the immunocompetent patient: risk factors and surgical management. Surg Infect (Larchmt) 4(2):199-204, 2003. e-Pub 2003. PMID: 12906720.
Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, Bodey G, Mardani M, Hachem R, Kontoyiannis D, Whimbey E, Rolston K. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 23(9):532-7, 2002. e-Pub 2002. PMID: 12269452.
Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest 121(4):1171-6, 2002. e-Pub 2002. PMID: 11948049.
Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 112(5):380-5, 2002. e-Pub 2002. PMID: 11904112.
Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 23(2):102-3, 2002. e-Pub 2002. PMID: 11893144.
Raad I, Hachem R, Tcholakian RK, Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46(2):327-32, 2002. e-Pub 2002. PMID: 11796338.
Hachem R, Raad I. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 23(1):43-4, 2002. e-Pub 2002. PMID: 11868893.
Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23(1):41-3, 2002. e-Pub 2002. PMID: 11868892.
Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33(10):1676-81, 2001. e-Pub 2001. PMID: 11568858.
Raad I, Hachem R, Hanna H, Girgawy E, Rolston K, Whimbey E, Husni R, Bodey G. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrob Agents Chemother 45(11):3202-4, 2001. e-Pub 2001. PMID: 11600379.
Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 20(6):432-4, 2001. e-Pub 2001. PMID: 11476449.
Raad I, Hachem R, Hanna H, Abi-Said D, Bivins C, Walsh G, Thornby J, Whimbey E, Huaringa A, Sukumaran A. Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. Ann Surg Oncol 8(2):179-86, 2001. e-Pub 2001. PMID: 11258785.
Minari A, Hachem R, Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32(2):186-90, 2001. e-Pub 2001. PMID: 11170906.
Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, Whimbey E, Hachem R, Raad I. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 160(17):2659-64, 2000. e-Pub 2000. PMID: 10999981.
Hachem, RY, Afif C, Cooksley C, Boktour M, Chatzinikolaou I, Khan A, Kontoyiannis D, Rolston KV, Raad II. Invasive aspergillosis (IA) In patients with leukemia and bone marrow transplant patients (pts): poor outcome despite aggressive therapy (abstract no. 3815). Blood 96(11):36b, 2000. e-Pub 2000.
Torres, HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube related multidrug-resistant Staphylococcus aureus empyema: could the chest tube be coated with antiseptics? . Infect Control Hosp Epidemiol, 2000. e-Pub 2000.
Hachem, R, Sumoza D, Hanna H, Girgawy E, Munsell M, Raad I. Clinical and Radiologic Predictors of Invasive Pulmonary Aspergillosis in Cancer Patients: Should the EORTC/MSG Criteria be Revised? . Cancer, 2000. e-Pub 2000.
Raad I, Bompart F, Hachem R. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis 18(3):199-202, 1999. e-Pub 1999. PMID: 10357054.
Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340(1):1-8, 1999. e-Pub 1999. PMID: 9878638.
Raad II, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M, Morck D. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 26(2):219-24, 1998. e-Pub 1998. PMID: 9468157.
Raad II, Hachem RY, Abi-Said D, Rolston KV, Whimbey E, Buzaid AC, Legha S. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer 82(2):403-11, 1998. e-Pub 1998. PMID: 9445199.
Hachem, RY, Raad I. Clinical presentation and management of methicillin-resistant Staphylococcus epidermidis (MRSE) bloodstream infections. Antibiotics for Clinicians 2((Suppl 1)):21-24, 1998. e-Pub 1998.
Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127(4):267-74, 1997. e-Pub 1997. PMID: 9265425.
Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25(1):149-51, 1997. e-Pub 1997. PMID: 9243049.
Hachem R, Raad I, Rolston KV, Whimbey E, Katz R, Tarrand J, Libshitz H. Cutaneous and pulmonary infections caused by Mycobacterium vaccae. Clin Infect Dis 23(1):173-5, 1996. e-Pub 1996. PMID: 8816149.
Raad I, Hachem R, Zermeno A, Dumo M, Bodey GP. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 17(11):1055-9, 1996. e-Pub 1996. PMID: 8718964.
Raad, II, Whimbey EE, Rolston KV, Abi-Said D, Hachem RY, Pandya RG, Ghaddar HM, Karl CL, Bodey GP. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer 77(7):1386-94, 1996. e-Pub 1996. PMID: 8608520.
Raad I, Hachem R, Leeds N, Sawaya R, Salem Z, Atweh S. Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain. Clin Infect Dis 22(3):572-4, 1996. e-Pub 1996. PMID: 8852983.
Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173(2):418-24, 1996. e-Pub 1996. PMID: 8568304.
Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 173(2):495-8, 1996. e-Pub 1996. PMID: 8568321.
Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39(11):2397-400, 1995. e-Pub 1995. PMID: 8585715.
Raad I, Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 20(3):709-11, 1995. e-Pub 1995. PMID: 7756502.
Karyotakis NC, Dignani MC, Hachem R, Anaissie EJ. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Antimicrob Agents Chemother 39(2):571-3, 1995. e-Pub 1995. PMID: 7726538.
Anaissie EJ, Hachem R, Karyotakis NC, Gokaslan A, Dignani MC, Stephens LC, Tin-U CK. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 38(11):2541-4, 1994. e-Pub 1994. PMID: 7872744.
Anaissie EJ, Karyotakis NC, Hachem R, Dignani MC, Rex JH, Paetznick V. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis 170(2):384-9, 1994. e-Pub 1994. PMID: 8035024.
Karyotakis NC, Anaissie EJ, Hachem R, Dignani MC, Samonis G. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. J Infect Dis 168(5):1311-3, 1993. e-Pub 1993. PMID: 8228370.
Anaissie E, Hachem R, KTin-U C, Stephens LC, Bodey GP. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun 61(4):1268-71, 1993. e-Pub 1993. PMID: 8454330.
Anaissie E, Gokaslan A, Hachem R, Rubin R, Griffin G, Robinson R, Sobel J, Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 15(5):781-7, 1992. e-Pub 1992. PMID: 1445976.
Anaissie EJ, Hachem R, Legrand C, Legenne P, Nelson P, Bodey GP. Lack of activity of amphotericin B in systemic murine fusarial infection. J Infect Dis 165(6):1155-7, 1992. e-Pub 1992. PMID: 1583339.
Legrand, C, Anaissie E, Hachem R, Nelson P, Bodey GP, Ro J. Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis 164:944-948, 1991. e-Pub 1991.
Ro J, Lee D, Legrand C, Anaissie E, Hachem R, Ayala A. Fusarium infection - experimental model. Mod Pathol 3, 1990. e-Pub 1990.
Reuben, A, Anaissie E, Nelson PE, Hachem R, Legrand C, Ho DH, Bodey GP. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth micro dilution method. Antimicrob Agents Chemother 33(9):1647-1649, 1989. e-Pub 1989.

Invited Articles

Chaftari AM, Hachem R, Raad I. Invited. International Hospital Equipment & Solutions, 2008. e-Pub 2008.
Kassis C, Granwehr B, Hachem R. Curvularia infections: Case reports and a review of the spectrum of disease along with therapeutic options. Journal of Invasive Fungal Infections 2(2):62-65, 2008. e-Pub 2008.

Review Articles

Viola, GM, Szvalb, AD, Malek, A, Chaftari, AP, Hachem, RY, Raad, II. Prevention of device-related infections in patients with cancer. CA Cancer Journal for Clinicians 73(2):147-163, 2023. e-Pub 2023. PMID: 36149820.
El Beaino M, Fares J, Malek A, Hachem R. Sphingomonas paucimobilis-related bone and soft-tissue infections: A systematic review. Int J Infect Dis 77:68-73, 2018. e-Pub 2018. PMID: 30267938.
Raad II, Chaftari AM, Torres HA, Ayoub EM, Narouz LI, Bartek J, Hachem R. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol 10(9):549-557, 2018. e-Pub 2018. PMID: 30310533.
Dib RW, Hachem R, Chaftari AM, Raad I. Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients. Mediterr J Hematol Infect Dis 10(1):e2018028, 2018. e-Pub 2018. PMID: 29755705.
Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21(4):385-92, 2008. e-Pub 2008. PMID: 18594291.
Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 20(7-8):1105-13, 2002. e-Pub 2002. PMID: 12449743.

Abstracts

Hachem R, Wehbe S, Raad I. Prognostic value of serum and bronchoalveolar lavage fluid galactomannan in invasive aspergillosis: an eight-year experience at a tertiary cancer centre. ESCMID Global 2025, 2025. e-Pub 2025.
Chaftari AM, Malek AE, Dagher H, Jiang Y, Hachem R, Raad I. Lung cancer and hematologic malignancy ( HM) patients are associated with the highest risk of progressing to severe disease and mortality in cancer patients with COVID-19. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Dagher H, Chaftari A, Hachem R, Mulanovich P, Jiang Y, Malek AE, Garnes ND, Borjan J, Mulanovich V, Raad I. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients admitted with COVID-19. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Brock P, Wechsler A, Chaftari A, Dagher H, Jiang Y, Lipe D, Chaftari P, Gaeta S, Johnson T, Coussirat D, Malek AE, Hachem R, Raad AI. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Gerges B, PhD, Rosenblatt J, PhD, Hachem R, MD, Chaftari A, MD, Raad I. In Vitro Activity of Tebipenem Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Malek AE, Dagher H, Hachem RY, Jiang Y, Chaftari A, Raad II. A Comparison of Chest CT Findings in Cancer and non-Cancer Patients with COVID-19. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Dagher H, Malek AE, Chaftari A, Subbiah IM, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Hachem R, Raad I. Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period. IDWeek2021, Virtual Conference, 2021. e-Pub 2021.
Malek AE, Chaftari P, Okhuysen PC, Dagher H, Torres HA, Hachem R, Chaftari AM, Viola GM, Kontoyiannis DP, Mulanovich VE, Raad II. Isoniazid therapy for latent tuberculosis infection in patients with cancer treated with checkpoint inhibitors immunotherapy. IDWeek 2021, Virtual Conference, 2021. e-Pub 2021.
Chaftari P, MD, Chaftari A, MD, Hachem R, MD, Yeung SJ, MD, Dagher H, Jiang Y, MS, Malek A, MD, Mulanovich VE, MD, Raad I, MD. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Malek AE, Chaftari P, Dagher HR, Hachem R, Chaftari AM, Viola GM, Raad II. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Chaftari A, Hachem R, Malek AE, Mulanovich V, Szvalb A, Jiang Y, Ali S, Deeba R, Chaftari P, Raad I. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Gerges BZ, PhD, Rosenblatt J, PhD, Truong Y, BS, Reitzel RA, PhD, Hachem R, MD, Raad II, MD. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Dagher H, Hachem R, Chaftari A, Jiang Y, Ali S, Deeba R, Shah S, Raad I. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Torres HA, Angelidakis GA, Jiang Y, Economides ME, Yibirin MY, Robert Orlowski MD, Champlin R, Verstovsek S, Raad II. Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without prior hematopoietic cell transplant recipients. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Hachem R, Datoguia T, Siddiqui B, Cruz AF, Mori N, Fakhreddine S, Lee D, Gorak E, Somer R, Bhinder A, Shelanski S, Dragivich T, Bayle A, Chemaly R, Mulanovich V, Adachi J, Malek A, Slavin M, Jiang Y, Chaftari A, Raad I. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study. ID Week 2020, Virtual Conference, Online, 2020. e-Pub 2020.
Malek A, Fares J, Khalil M, Hachem R, Chaftari AM, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich V, Viola G, Raad I. The Impact of Checkpoint Inhibitor Immunotherapy on Infections in Lung Cancer Patients. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Vargas-Cruz N, Rosenblatt J, Reitzel R, Khalil K, Raad I. In vitro antimicrobial efficacy of novel antimicrobial Dacron vascular grafts in the inhibition of multidrug resistant gram-negative biofilm. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Wilson Dib R, Khalil C, Fares J, Dandachi D, Hachem R, Jiang Y, Chaftari AM, Raad I. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy versus Solid Tumor. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Gerges B, Reitzel R, Rosenblatt J, Hachem R, Raad I. Assessment of biofilm eradication and cytotoxicity of a novel polygalacturonic acid + caprylic acid wound ointment compared to antiseptic wound ointments. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Fares J, Khalil M, Chaftari AM, Jiang Y, Hachem R, Raad I. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Reitzel R, Rosenblatt J, Bahgat G, Vargas-Cruz N, Hachem R, Kontoyiannis D, Raad I. Minocycline EDTA Ethanol (MEDTA+EtOH) lock is highly efficacious in rapidly eradicating Candida auris biofilm. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Khalil A, Fares J, Chaftari AM, Jiang Y, Deeba R, Ali S, Hachem R, Raad I. The Impact of Early Central Venous Catheter Removal in the Management of Enterococcus Central Line-Associated Bloodstream Infections. ID Week 2019, Washington, DC, 2019. e-Pub 2019.
Bahgat G, Reitzel R, Rosenblatt J, Hachem R, Raad I. Assessment of biofilm eradication and cytotoxicity of a novel polygalacturonic acid + caprylic acid ointment compared to common antiseptic ointments used in wounds. Division of Internal Medicine Research Retreat, June 2019, MD Anderson Cancer Center Houston, TX, 2019. e-Pub 2019.
Fares J, Khalil M, Chaftari AM, Jiang Y, Hachem R, Raad I. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia. Division of Internal Medicine Research Retreat, June 2019, MD Anderson Cancer Center Houston, TX, 2019. e-Pub 2019.
Khalil M, Fares J, Wilson Dib R, Hachem R, Jiang Y, Chaftari AM, Raad I. Invasive Pulmonary Aspergillosis: Comparative Analysis of Patients with Underlying Solid and Hematologic Malignancy. Division of Internal Medicine Research Retreat, June 2019, MD Anderson Cancer Center Houston, TX, 2019. e-Pub 2019.
Rolston K, Bahgat G, Shelburne S, Aitken S, Hachem R, Raad I. In vitro Activity of Imipenem/relebactam and Comparator Agents Against Gram-negative Isolates Recovered from Cancer Patients. Division of Internal Medicine Research Retreat, June 2019, MD Anderson Cancer Center Houston, TX, 2019. e-Pub 2019.
Hachem R, Reitzel R, Vargas-Cruz N, Holland TL, Fowler Jr VG, Raad I. Whole Genome Sequencing Analysis of a Large Cohort of Staphylococcus epidermidis Blood Culture Positive Isolates from a Multicenter Clinical Trial. ID Week 2018, San Francisco, CA, 2018. e-Pub 2018.
Reitzel R, Rosenblatt J, Hachem R, Chaftari AM, Wilson Dib R, Raad I. Repeated exposures to Minocycline/Rifampin and + Chlorhexidine combination used to coat catheters fails to induce antimicrobial resistance. ID Week 2018, San Francisco, CA, 2018. e-Pub 2018.
Dib RW, FernÃ¡ndez-Cruz A, Jiang Y, Hachem R, Chaftari AM, Raad I. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes. ID Week 2018, San Francisco, CA, 2018. e-Pub 2018.
Wilson Dib R, Chaftari AM, Hachem R, Jiang Y, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy. ID Week 2018, San Francisco, CA, 2018. e-Pub 2018.
Wilson Dib R, Chaftari AM, Hachem R, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis (ST): The Role of Anticoagulation Therapy. Division of Internal Medicine Research Retreat. Division of Internal Medicine Research Retreat, May 3-4, 2018, MD Anderson Cancer Center Houston, TX, 2018. e-Pub 2018.
Reitzel R, Chaftari AM, Wilson Dib R, Fieldman A, Numan L, Hachem R, Rosenblatt J, Raad I. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas : a 26,000 parenteral nutrition-day experience. Division of Internal Medicine Research Retreat, May 3-4, 2018, MD Anderson Cancer Center Houston, TX, 2018. e-Pub 2018.
Rosenblatt J, Reitzel R, Vargas-Cruz N, Hachem R, Chaftari AM, Wilson Dib R, Kontoyiannis D, Raad I. Candida auris Biofilm Eradication by Nitroglycerin-Citrate-Ethanol Catheter Lock Solution. Division of Internal Medicine Research Retreat. Division of Internal Medicine Research Retreat, May 3-4, 2018, MD Anderson Cancer Center Houston, TX, 2018. e-Pub 2018.
Hachem R, Reitzel R, Rosenblatt J, Vargas-Cruz N, Hill L, Moore L, Meyer J, Gagea M, Raad I. Porcine Wound Healing Model with a Novel Non-Antibiotic Wound Ointment. Division of Internal Medicine Research Retreat. Division of Internal Medicine Research Retreat, May 3-4, 2018, MD Anderson Cancer Center Houston, TX, 2018. e-Pub 2018.
Rosenblatt J, Reitzel RA, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Catheter Lock with Minocycline, EDTA and Ethanol for Salvaging of Central Venous Catheters in the Setting of Catheter Related Bloodstream Infections. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Chaftari AM, MD, Raad S, Hachem R, Shah P, Jiang J, Natividad E, Cleeland C, Rosenblatt J, Raad I. Unnecessary removal of central venous catheters in cancer patients with bloodstream infections: impact on symptom burden. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Wilson Dib R, Chaftari AM, Ghaly F, Jiang Y, Hachem R, Raad. Comparing diagnostic driven approaches to empiric therapy in the treatment of invasive aspergillosis in patients with hematologic malignancy. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad. Comparative efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in vitromodel of Catheter-Related Fungemia. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Reitzel R, Chaftari AM, Feldman A, Numan L, Hachem R, Rosenblatt J, Raad. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas MD Anderson Cancer Center: a 26,000 parenteral nutrition-day experience. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Foley catheter with peri-urethral antimicrobial irrigation for the prevention of catheter associated urinary tract infections – assessment in an in vitro model. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
V. Novel, low-toxicity, disinfectant solution for rapid kill of common resistant pathogens responsible for hospital associated infections. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Holland TL, Boucher HW, Raad I, Anderson DJ, Cosgrove SE, Aycock S, MSN, Baddley JW, S-C C, Chu VH, Cook PP, Corey GR, Daly JS, Hachem RY, Chaftari AM, Horton JM, Jenkins TC, Gu J, Levine DP, Miro JM, Riska P, Rubin ZA, Rupp ME, Schrank J, Sims M, Wray D, Zervos MJ, Fowler V. Doing the same with less: A randomized, multinational, open-label, adjudicator-blinded trial of an algorithm vs. standard of care to determine treatment duration for Staphylococcal bacteremia. ID Week 2017, San Diego, CA, 2017. e-Pub 2017.
Rosenblatt J, Reitzel R, MS, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Environmental disinfectant solutions achieves rapid kill against a broad spectrum of common resistant pathogens responsible for hospital associated infections. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Rosenblatt, J, Reitzel, R, Hachem, R, Chaftari, A, Raad, I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. 2017 GAP, MD Anderson Cancer Center, May 9–11, 2017, Houston, TX, 2017. e-Pub 2017.
Chaftari AM, Hachem R, Shah P, Hussain A, Al Hamal Z, Yousif A, Jordan M, Michael M, Raad I. Changing Epidemiology of Central Line Associated Blood Stream Infections (CLABSI) in Cancer Patients. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Rosenblatt J, Reitzel R, MS, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Antimicrobial Foley Catheter Flush/External Surface Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – An in vitro model. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Raad I, Chaftari AM, Hachem R, Shah P, MD, Natividad E, Cleeland C, Rosenblatt J. Removal and Insertion of Central Venous Catheters for Bloodstream Infections Is Associated with High Symptom Burden. 2017 GAP, MD Anderson Cancer Center, May 9–11, 2017, Houston, TX, 2017. e-Pub 2017.
Hachem, R, Retizel, R, Chaftari, A, Rolston, Raad K, I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparator Agents against Resistant Clinical Bacteria Isolates from cancer patients. 2017 GAP, MD Anderson Cancer Center, May 9–11, 2017, Houston, TX, 2017. e-Pub 2017.
Vargas-Cruz, N, Reitzel, R, Rosenblatt, J, Jamal, M, Szvalb, A, Chaftari AM, Hachem, R, Raad I. Activity of Antimicrobial Percutaneous Nephrostomy Catheters for the prevention of Renal Infections: In vitro studies. 2017 GAP, MD Anderson Cancer Center, May 9–11, 2017, Houston, TX, 2017. e-Pub 2017.
Rosenblatt J, PhD, Reitzel RA, MS, Vargas-Cruz N, BS, Chaftari AM, Hachem R, Raad I. Comparative efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in vitro model of Catheter-Related Fungemia. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Chaftari AM, Raad S, MS, Hachem R, Shah P, Natividad E, Cleeland C, Rosenblatt J, Raad I. Rates of Unnecessary Removal and Insertion of Central Venous Catheters in Cancer Patients with for Bloodstream Infections: Impact on Symptom Burden. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Rosenblatt, J, Reitzel, R, Chaftari, A, Hachem, R, Raad, I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an extended panel of highly resistant Pathogens. 2017 GAP, MD Anderson Cancer Center, May 9–11, 2017, Houston, TX, 2017. e-Pub 2017.
Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola G M, Sapna A, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Division of Internal Medicine Research Retreat, May 11-12, 2017, MD Anderson Cancer Center Houston, TX, 2017. e-Pub 2017.
Rosenblatt, J, Reitzel, R, Hachem, R, Chaftari, A, Raad, I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, TX, 2017. e-Pub 2017.
Vargas-Cruz, N, Reitzel, R, Rosenblatt, J, Jamal, M, Szvalb, A, Chaftari AM, Hachem, R, Raad, I. Activity of Antimicrobial Percutaneous Nephrostomy Catheters for the prevention of Renal Infections: In vitro studies. Antimicrobial Resistance Symposium. The University of Texas Health Science Center-Houston, TX, 2017. e-Pub 2017.
Rosenblatt, J, Reitzel, R, Chaftari, A, Hachem, R, Raad, I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an extended panel of highly resistant Pathogens including Vancomycin intermediate Staphylococcus aureus (VISA) and Carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, TX, 2017. e-Pub 2017.
Hachem R, Retizel, R, Chaftari A, Rolston, K Raad I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparator Agents against Resistant Clinical Bacteria Isolates from cancer patients. Antimicrobial Resistance Symposium,. Antimicrobial Resistance Symposium, The University of Texas Health Science Center-Houston, TX, 2017. e-Pub 2017.
Rosenblatt J, Reitzel R, Hachem R, A-M C, Raad I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
Numan Y, Shelburne S, Hachem R, Ghaoui S, A-M C, Raad I. Molecular Epidemiology Determinants of Invasive S. Epidermidis in Cancer Patients. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
Shah P, Hachem R, A-M C, Hussain A, Al Hamal Z, Yousif A, Jordan M, Micheal M, Raad I. Changing Epidemiology of Central Line Associated Blood Stream Infections (CLABSI) in Cancer Patients: Onset after Insertion. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
Rosenblatt J, Reitzel R, A-M C, Hachem R, Raad I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an Extended Panel of Highly Resistant Pathogens Including Vancomycin Intermediate Staphylococcus aureus (VISA) and Carbapenem-resistantEnterobacteriaceae (CRE). ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
A-M C, Chaftari P, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Elickalputhenpura B, Tarrand J, Raad I. Improvement in the Diagnosis of Patients With Central Line Related Bloodstream Infections by Proper Blood Culture Drawing and Labeling in an Emergency Center. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
El Haddad H, Michael M, Hachem R, A-M C, Jiang Y, Yousif A, Raad S, Jordan M, Raad I. El Haddad H, Michael M, Hachem R, Chaftari A-M, Jiang Y, Yousif A, Raad S, Jordan M, Raad I. The Role of Procalcitonin in Guiding Antimicrobial Therapy Duration in Cancer Patients with Sepsis or Bloodstream Infections. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
El Haddad H, Michael M, Hachem R, A-M C, Jiang Y, Yousif A, Raad S, Jordan M, Raad I. The Role of Procalcitonin in Guiding Antimicrobial Therapy Duration in Cancer Patients with Sepsis or Bloodstream Infections. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
Hachem R, Szvalb AD, Taremi M, Granwehr B, Viola GM, Sapna A, Assaf A, Numan Y, Shah P, Felix E, Natividad E, Jiang Y Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Related Bloodstream Infections (CRBSI) in Cancer Patients. ID Week 2016, New Orleans, LA,, 2016. e-Pub 2016.
Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, A-M C, Raad I. To Compare the Safety and Efficacy of Voriconazole versus Posaconazole in the Prevention of Invasive Fungal Infections in High Risk Patients with Hematologic Malignancies or Hematopoietic Stem Cell Transplant. ID Week 2016, New Orleans, LA, 2016. e-Pub 2016.
Ray H, Chaftar AM, Hussain A, Al Hamal Z, Yousif A, Jordan M, Micheal M, Issam Raad I. Changing Epidemiology of Central Line Associated Blood Stream Infections (CLABSI) in Cancer Patients: Onset after Insertion. ID Week 2016, New Orleans, LA,, 2016. e-Pub 2016.
Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Antimicrobial Efficacy of Chlorhexidine-Minocycline/Rifampin (CHX-M/R) Coated Nephrostomy Catheter against Multi-drug Resistant Pathogens including Carbapenem-Resistant Enterobacteriaceae. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Raad I, Chaftari AC, Zakhour R, Yousif A, Jiang Y, Jordan, M, Al Hamal Z, Viola G. Successful Salvage of vascular access in Central Line Associated Bloodstream Infections (CLABSI) Using Catheter Lock Consisting of Minocycline, EDTA and 25% Ethanol (M-EDTA-ETOH). ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Zakhour R, Hussain A, Hachem R, Jiang Y, Michael M, Chaftari AM, Raad I. Management and Outcome of Catheter-related Bloodstream Infections in a pediatric population: How is it different from adult population?. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Jamal J, Hachem, R, Rosenblatt J, Mcarthur M, Felix F, Jiang Y, Tailor, R, Raad I. Development of Antimicrobial Gendine Coated Central Catheters: In Vivo Biocompatibility and In Vitro Efficacy systemic exposures of CHX and gentian violet from the gendine catheters were well within safe levels. ID Week. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Development and Efficacy of Chlorhexidine (CHX)-Minocycline/Rifampin (MR) Impregnated Penile Implants Against Resistance. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Hachem R, Reitzel R, Rolston K, Raad I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) against 511 Gram-Negative Clinical Isolates obtained from cancer patients. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
Chaftari AM, Alshuaibi M, Reitzel R, Jamal MA, Mary Jordan M, Jiang Y, Yousif A, Garoge K, Deshmukh P, Al Hamal Z, Jabbour J, Alex Hanania A, Sammy Raad S, Ray Hachem R, Raad I. Procalcitonin and Interleukin-6: Biomarkers of Cancer and Infection. ID Week 2014, Philadelphia, PA, 10/2014, 2014. e-Pub 2014.
Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, MD, Viola G, Granwwehr B, Gagel A, Ying Jiang Y, Shuaibi M, Issam Raad I. Efficacy and safety of telavancin in the treatment of gram-positive bloodstream infections in cancer patients. ID Week 2014, Philadelphia, PA, 10/2014, 2014. e-Pub 2014.
Jordan M, Al Hamal Z, Yousif A, Deshmukh P, Garoge K, Jiang Y, Hachem R, Chaftari AM, Raad I. How Often Is Central Line-Associated Blood Stream Infection (CLABSI) Identified As Catheter-Related Blood Stream Infection (CRBSI) In Cancer Patients? Challenging The New Guidelines. 54th Interscience Conference on Antimicrobial Agents and Chemotherap, Washington, DC, 9/2014, 2014. e-Pub 2014.
Rosenblatt, J, Reitzel, RA, Jamal, Hirsch-Ginsberg M, CF, Al Shuaibi M, Chaftari, AM, Hachem, R, Raad. Optimized Glyceryl Trinitrate (GTN)-Citrate-Ethanol Non-antibiotic, Antimicrobial Catheter Lock Solution for Prevention Of Central Line Associated Bloodstream Infections (CLABSIs). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 9/2014, 2014. e-Pub 2014.
Garoge K, Jamal MA, Rosenblatt J, Chaftari A, Hachem R, Raad II. Development Of Antimicrobial Coated Cannula For Continuous Subcutaneous Insulin Infusion (CSII) For Extended Durations. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 9/2014, 2014. e-Pub 2014.
Hachem R, Chaftari AM, Yousif A, Al Hamal Z, Garoge. A Novel Lock Solution For Salvaging Central Venous Catheter (CVC) In The Setting Of A Central Line Associated Bloodstream Infection (CLABSI). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 9/2014, 2014. e-Pub 2014.
Chaftari AM, Hachem R, Jiang Y, Raad I. Use of Antimicrobial Central Venous Catheters for Exchange Over Guidewire in Staphylococcus aureus Central Line Associated Bloodstream Infection. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
Chaftari A, Alshuaibi M, Jamal M, Reitzel R, El Zakhem A, Jiang Y, Hachem R, Raad I. Biomarkers and Correlates of Protection. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
Hachem R, Chaftari AM, El Zakhem A, Viola GM, Granwehr B, Gagel A, Jiang Y, Alshuaibi M Raad I. Efficacy and safety of telavancin in the treatment of Gram-positive bloodstream infections in cancer patients. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
Hachem R, El Helou G, El Zakhem A, Shomali W, Jiang Y. Caspofungin and Voriconazole as Primary and Salvage Therapy for Patients. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
Reitzel R, Rosenblatt J, Jiang Y, Hachem RY, Raad II. Antimicrobial Gendine Gloves for the prevention of the emerging multidrug resistant pathogens transmission. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Denver, CO, 2013. e-Pub 2013.
Jamal M, Chaftari M, Dvorak T, El Zakehm A, Rosenblatt J, Jiang Y, Hachem RY, Raad II. Prevention Of Transmission Of Multi-drug Resistant Organisms During Catheter Exchange Using Antimicrobial Catheters. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Denver, CO, 2013. e-Pub 2013.
Jamal M, Rosenblatt J, Hachem R, Ying J, Chaftari AM, Raad I. Prevention of Gram Negative Bacterial Biofilm on Central Venous Catheters (CVCs) with Chlorhexidine-Minocycline/Rifampin by a Segregated Coating Method. 2013 Divison of Internal Medicine Research Retreat, 2013. e-Pub 2013.
Chaftari AM, Alshuaibi M, Jamal M, Reitzel R, Zakhem A, Jiang Y, Hachem R, Raad I. Role of Procalcitonin in Cancer Patients with Infections. 2013 Division of Internal Medicine Research Retreat, 2013. e-Pub 2013.
El Zakhem A, Chaftari AM, Ray, H, Jiang Y, Raad I. Use of Antimicrobial Central Venous Catheters for Exchange Over Guidewire in Staphylococcus aureus. 2013 Infections in Cancer Sympsoium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
El Zakhem A, Chaftari AM, Hachem, Bahu R, El Helou G, AlShuaibi M Raad I. Staphylococcus Aureus (SA) Central Line Associated Bloodstream Infections (CLABSI) in Cancer Patients: Removal of the Catheter and Duration of Therapy. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
Hachem R, Gilbert EH, Bahu R, Chaftari AM, Reitzel R, Dvorak T, Ying J, Tarrand J, Raad I. The Role of Procalcitonin and Pro-adrenomedullin in Differentiating the Causative Organisms in Bloodstream Infections. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
Mohamed J, Chaftari AM, Dvorak T, El Zakhem A, Rosenblatt J, Jiang Y, Hachem R, Raad I. Prevention of transmission of methicillin-resistant Staphylococcus aureus during catheter exchange using antimicrobial catheters. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
Mohamed JA, Chaftari A, Hachem RY, Alshuaibi M, Raad I. Augmenting antibiotic-coated catheters (CVC) activity against bacterial biofilm adherence by impregnating the CVC with verapamil. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
El Zakhem A, Chaftari AM, Hachem R, Bahu R, El Helou G, Alshuaibi M, Raad I. Staphylococcus aureus (SA) central line associated bloodstream infections (CLABSI) in cancer patients: removal of the catheter and duration of therapyI. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
Shomali W, Hachem R, Chaftari AM, Bahu R, Jiang Y, Reitzel R, El Helou G, Raad I. The role of procalcitonin and pro-adrenomedullin in differentiating organisms causing staphylococcal bacteremia. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
Rosenblatt J, Hachem RY, Dvorak T, Reitzel R, Chaftari A, Alshuaibi M, Raad I. Rosenblatt J, Hachem RY, Dvorak T, Reitzel R, Chaftari A, Alshuaibi M, Raad I. Glyceryl trinitrate (GTN) is useful as a novel non-antibiotic catheter lock for the prevention of intraluminal catheter biofilm colonization. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
Mori N, DuPont H, Jiang ZD, El Zakhem A, Williams P, Van Tassel A, Cantu S, Good C, Dvorak T, Reitzel R, Tarrand JJ, Raad I, Chemaly R, Adachi JA. Increasing rates of multi-drug resistant organism bloodstream infections in a comprehensive cancer center: rifaximin as a novel alternative for antimicrobial prophylaxis. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
Rosenblatt J, Hachem RY, Reitzel R, Chaftari A, Raad I. Pathogenesis and prevention of ventilator-associated pneumonia (VAP): an in vitro model using antimicrobial–coated endotracheal tube (ETT). 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
Hachem R, El Helou G, El Zakhem A, Shomali W, Jiang Y, Chaftari AM, Raad I. Caspofungin and voriconazole as primary and salvage therapy for patients with invasive aspergillosis in hematologic malignacy. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
Reitzel R, Rosenblatt J, Hachem RY, Raad I. Novel water based method of impregnating exam gloves with gendine antiseptic. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
Mohamed JA, Hachem RY, Chaftari A, Jiang J, Raad I. Mohamed JA, Hachem RY, Chaftari A, Jiang J, Raad I. Efficacy of a novel gendine coated peripherally inserted central venous catheters (PICC) against multidrug-resistant pathogens. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
Hachem R, Debiane LG, Al Wohoush I, Jiang Y, A-M C, Raad I. Comparing biomarker procalcitonin (PCT) and Pro-adrenomedullin (proADM) as a predictor of response to antibiotics in critically ill cancer patients with bacteremia and sepsis. 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
El Helou G, Hachem R, A-M C, Tarrand J, Jiang Y, Raad I. Rapidly growing mycobacteria (RGM) bacteremia in immunocompromised patients: clinical experience of 74 patients at M.D. Anderson Cancer Center. 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
Hachem RY, Mohamed JA, Reitzel RA, Jiang Y, Dvorak T, A-M C, Raad II. Comparison of three antimicrobial coated peripherally inserted central venous catheters (PICCs): What is on the horizon?. 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
Shomali W, Bahu R, Jiang Y, Hanania A, Raad S, A-M C, Hachem R, Raad I. Can Procalcitonin (PCT) Distinguish Infectious Fever from Tumor-Related Fever in Non-Neutropenic Cancer Patients (NNCP)?. 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
Bahu R, Shomali W, Ahrar K, A-M C, Jiang Y, Hachem R, Raad I. Nephrostomy Tube Related Infection (NTRI): Epidemiology, Risk Factors, and Infection Rate in Cancer Patients. 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
Mohamed JA, Chaftari A, Reitzel RA, Jiang Y, Dvorak T, Hachem R, I Raad AI. Prolonged antimicrobial durability of combination chlorhexidine (CHX) and minocycline/rifampin (M/R) coated central venous catheters (CVC). 49th Infectious Diseases Society of America, 2011. e-Pub 2011.
Debiane L, Hachem R, Al Wohoush I, Jabbour J, Jiang Y, Al Akhrass F, A-M C, Raad I. Procalcitonin is predictive of response to antibiotics but does not differentiate infection from advanced cancer in hematologic malignancy. 48th Infectious Diseases Society of America, October 21-24, 2010, Vancouver, BC, 2010. e-Pub 2010.
Al Wohoush I, Mihu C, Kontoyiannis D, Jiang Y, Hachem R, Rolston KVI, Raad I. Invasive mold infections in patients with solid tumors. 48th Infectious Diseases Society of America, October 21-24, 2010, Vancouver, BC, 2010. e-Pub 2010.
Mohamed JA, Reitzel R, A-M C, Hachem R, Raad I. Activity of antimicrobial-coated endotracheal tubes (ETT) in preventing the biofilm colonization of resistant bacteria in a biofilm model withneutralizing broth. 48th Infectious Diseases Society of America, October 21-24, 2010, Vancouver, BC, 2010. e-Pub 2010.
Debiane L, Hachem R, Al Wohoush I, Jiang Y, A-M C, Raad I. Pro-adrenomedullin is predictive of response to antibiotics in critically ill cancer patients with bacteremia and sepsis. 48th Infectious Diseases Society of America, October 21-24, 2010, Vancouver, BC, 2010. e-Pub 2010.
Raad II, Reitzel R, Dvorak T, Yiang Y, Chaftari A, Hachem R. Comparing chelator-based catheter lock solutions in eradicating organisms in biofilm on catheter surfaces. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2010, Boston, MA, 2010. e-Pub 2010.
Raad II, Al Akhrass F, Al Wohoush I, Reitzel R, Hachem R. Rhodococcus bacteremia is mostly catheter related and associated with biofilm formation. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2010, Boston, MA, 2010. e-Pub 2010.
Raad II, Mohamed J, Reitzel R, Jiang Y, Chaftari A, Hachem R. The extended broad-spectrum activity of 2nd generation minocycline and rifampin-coated catheters against bacteria and fungi. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2010, Boston, MA, 2010. e-Pub 2010.
Al Akhrass F, Mohamed JA, Hachem R, Raad II. Catheter-related bacteremia caused by nocardia: biofilm formation and prevention by catheter lock solutions. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2010, Boston, MA, 2010. e-Pub 2010.
Raad II, Dvorak T, Reitzel R, Jiang Y, Hachem R. Dowanol as bioenhancer of chlorhexidine to achieve a rapid kill against MRSA. 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2010, Boston, MA, 2010. e-Pub 2010.
Raad I, Ramos E, Hachem R, Jiang Y, Torres H, Al-Akhrass F, Kontoyiannis D, Safdar A. Are White Blood Cell Transfusions (WBCT) Useful in the Salvage Treatment of Invasive Aspergillosis (IA) in Neutropenic Hematologic Malignancy Patients (HMP)?. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2009, San Francisco, CA, 2009. e-Pub 2009.
Raad I, Hachem R, Dvorak T, Reitzel. Evaluating the Efficacy of Anti-Infective Endotracheal Tubes (ETT) in Preventing Biofilm Colonization (BC) of Multi-resistant Bacteria (MDRB) Associated with Ventilator-Associated Pneumonia (VAP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2009, San Francisco, CA, 2009. e-Pub 2009.
Chaftari A, Hachem R, Kassis C, El Issa H, Kassar R, Jiang Y, Raad I. Novel Approach Using Antimicrobial Catheters for Catheter Exchange in Patients with Catheter-Related Bacteremia (CRB): A Matched Controlled Study. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2009, San Francisco, CA, 2009. e-Pub 2009.
Raad I, Hachem R, Ramos E, Kassis C, Jiang Y, Afif C, Torres H, Kontoyiannis D. Posaconazole (Posa) and Echinocandins (Ech) Combination: A Promising Salvage Therapy of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2009, San Francisco, CA, 2009. e-Pub 2009.
Hachem R, Ramos E, Kassis C, Jiang Y, Kontoyiannis D, Raad I. Comparing the Outcome of Invasive Aspergillosis (IA) Caused by Aspergillus terreus to A. fumigatus in Hematologic Malignancies Patients (HMP). 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2009, San Francisco, CA, 2009. e-Pub 2009.
Shah JN, Hachem RY, Rathod DB, Adachi JA, Mulanovich VE, Raad II, Chemaly RF. Outcome of MRSA bacteremia (BSI) in cancer patients treated with vancomycin. 47th Annual Meeting of the Infectious Diseases Society of America. October 29 – November 1, 2009, Philadelphia, PA, 2009. e-Pub 2009.
Shah JN, Vigil KJ, Hachem RY, Mihu NC, Mulanovich VE, Chemaly RF. Outcome of parainfluenza infection in pediatric cancer patients. 47th Annual Meeting of the Infectious Diseases Society of America. October 29 – November 1, 2009, Philadelphia, PA, 2009. e-Pub 2009.
Adachi J, Vigil K, Dvorak T, Hachem R, Chemaly R, Raad I. Molecular epidemiology of a clonal outbreak of epidemic multidrug-resistant (MDR) escherichia coli causing bloodstream infection in cancer patients, Abstract #08-060. Multinational Association of Supportive Care in Cancer (MAST) 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):658, 2008. e-Pub 2008.
Ramos E, Hachem R, Adachi J, Rolston K, Raad I, Chemaly R. Methicillin resistant staphylococcus aureus pneumonia in cancer patients: High failure rate with vancomycin, Abstract #08-069. Multinational Association of Supportive Care in Cancer (MAST) 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):663, 2008. e-Pub 2008.
Hanmod S, Khoury A, Adachi J, Hachem R, Safdar A, Chemaly R. Cytomegalovirus infection in patients with solid tumors, Abstract #08-065. Multinational Association of Supportive Care in Cancer (MAST) 2008 International Symposium Supportive Care in Cancer, Houston, TX 16(6):661, 2008. e-Pub 2008.
Rivera J, Kassar R, Kassis C, Dvorak T, Gohar A, Hachem R, Raad I. When does molecular genotyping (MG) and phenotyping of coagulase negative staphylococci (CNS) isolated from blood culture (BC) correlate with clinical/CDC criteria for true bacteremia. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Ramos ER, Hachem R, Mulanovich V, Adachi J, Kontoyiannis D, Rolston K, Safdar A, Raad II, Chemaly RF. Characteristics and outcome of methicillin resistant staphylococcus aureus pneumonia (MRSA-p) in cancer patients (pts) after initial therapy with vancomycin. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008, 2008. e-Pub 2008.
Chemaly RF, Hanmod S, Mulanovich V, Adachi J, Rolston K, Raad I, Hachem R. Tigecycline usage in cancer patients with serious infections: A report on 110 cases from a single institution. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Hachem R, Rivera J, Jiang J, Reitzel R, Han XY, Raad I. The diagnostic utility of quantitative PCR (qPCR) and galactomannan (GM-EIA) for the diagnosis of invasive aspergillosis (IA) in cancer pateints receiving anti-mold therapy (AMT). 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Kassar R, Hachem R, Ghannam D, Jiang J, Raad I. Should the catheter be removed in patients with true coagulase negative staphylococcal (CNS) bacteremia?. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Ghide S, Jiang J, Hachem R, Chaftari AM, Tarrand J, Raad I. Catheter-related corynebacterium bacteremia (CRCB): Should the catheter be removed and vancomycin (Vanc) administered?. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Kassis C, Rangaraj G, Jiang Y, Hachem R, Raad I. Role of time to positivity (TTP) and quantitative blood culture (QBC) in differentialing coagulase negative staphylococcal bacteremia from contamination in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Rangaraj G, Granwehr B, Hachem R, Jiang J, Raad I. Fluroquinolone prophylaxis and the risk of breakthrough bacteremia caused by multi-drug resistant (MDR) organisms in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Campo M, Hachem R, Jiang Y, Chemaly R, Carriol-Marquez M, Hulton K, Raad I. The impact of panton valentine leukocidin (PVL) exotoxin on the outcome of cancer patients with methicillin-resistant staphylococcus aureus (MRSA) Infection. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Ahmed SI, Hachem RY, Adachi JA. Clinical outcome of multidrug-resistance (MDR) gram-negative (GN) infections resistant to colistin in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Campo M, Hachem R, Jiang J, Chemaly R, Carrilo-Marquez M, Hulten K, Raad I. The impact of panton valentine leukocidin (PVL) exotoxin on the outcome of cancer patients with methicillin-resistant staphylococcus aureus (MRSA) infection. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Reitzel R, Dvorak T, Chaiban G, Yiang J, Hachem R, Raad I. Comparing the efficacy of novel anti-infective urinary catheters: The role of gendine-impregnated catheters (GND-UC) in preventing the adherence of multidrug-resistant organisms (MDRO). 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Kassar R, Hachem R, Jiang J, Tarrand J, Raad I. Management of catheter-related bacillus bacteremia (CRBB): The need for catheter (CVC) removal. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Chaftari AM, Hachem R, Mulanovich V, Chemaly R, Adachi J, Kassar R, Ramos E, Jiang J, Raad I. Efficacy and Safety of Daptomycin in the treatment of gram positive catheter-related bloodstream infections (CRBSI) in cancer patients. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 2008. e-Pub 2008.
Adachi JA, Vigil KJ, Aboufaycal H, Dvorak T, Hachem R, Tarrand JJ, Perego CA, Williams PA, Chemaly RF, Rolston KV, Raad II. Molecular Epidemiology of a Clonal Outbreak of Epidemic Multidrug-Resistant (MDR) Escherichia coli Causing Bloodstream Infection in Cancer Patients. Infectious Diseases Society of America (IDSA) 45th Annual Meeting, San Diego, CA, 2007. e-Pub 2007.
Ramos E, Youssef S, Jiang Y, Wright S, Pham-Williams T, Fang X, Hachem R, Raad. Micrococcus sp Bacteremia in Cancer Patients: The Role of Catheters and Cytokines (GCSF). Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, CA, 2007. e-Pub 2007.
Ramos E, Hachem R, Mulanovich V, Adachi J, Kontoyiannis D, Rolston K, Safdar A, Raad I, Chemaly RF. MRSA Pneumonia in Cancer Patients: High Failure rate with Vancomycin. Infectious Diseases Society of America (IDSA) 45th Annual Meeting, San Diego, CA, 2007. e-Pub 2007.
Ghannam DE, Hachem R, Jiang Y, Rangaraj GR, Raad II. CoagulaseNegative Staphylococcal Bacteremia in Cancer Patients: Optimal Duration of Antibiotic Therapy and Effect of Central Venous Catheter Removal. Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, CA, 2007. e-Pub 2007.
Rangaraj GR, Hachem R, Ghannam D, Jiang Y, Raad II. Breakthrough Bacteremia Epidemiology and Risk Factors in Cancer Patients. Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, CA, 2007. e-Pub 2007.
Raad II, Hachem R, Reitzel R, Dvorak T, Jiang Y, Fang X, Ramos E, Chemaly RF. Gardine Antispetic Gloves Protect Health Care Workers from Resistant Pathogens. Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, CA, 2007. e-Pub 2007.
Chemaly RF, Sharma PS, Youssef S, Gerber D, Hachem R, Raad II. Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter Related Bacteremia (CRB) in Cancer Patients receiving High Dose Interleukin (IL-2). Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, CA, 2007. e-Pub 2007.
Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Kantarjian H, Raad II. Galactomannan Enzyme Immunoassay (GM-EIA): Low Sensitivity for Aspergillus fumigatus Infection in Cancer Patients. Intersicence Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, Illinois, 2007. e-Pub 2007.
Hachem R, Chemaly RF, Jiang Y, Reitzel R, Dvorak T, Fang X, Raad II. Anti-adherence Activity and Antimicrobial Durability of Anto-infective-Coated Catheters Against Mulitdrug-Resistant Bacteria. Intersicence Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, Illinois, 2007. e-Pub 2007.
Raad I, Hachem R, Jiang Y, Kantarjian H, Champlin R, Kontoyiannis D. Combination Salvage Therapy of Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM): Which Caspofungin-Containing Regimen?. Intersicence Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, Illinois, 2007. e-Pub 2007.
Shukrallah B, Hanna H, Ghannam D, Chatzinikolaou I, Hachem R, Raad I. Clinical response (CR) within 24 hours following catheter removal is useful in diagnosing catheter-related bloodstream infection (CRBSI). 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly R, Raad I. Comparative analysis of vancomycin resistant Enterococcus (VRE) faecalis vs VRE faeciumin cancer patients. 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
Hachem RY, Boktour MR, Hanna HA, Kontoyiannis DP, Keutgen X, Shukrallah B, Hanna E, Raad II. Sinus surgery (SS) improves the outcome of invasive Aspergillus sinusitis in neutropenic patients with hematologic malignancy (HM). 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
Shukrallah B, Ghannam D, Hackett B, Keutgen X, Jiang Y, Hachem R, Chemaly R, Kontoyiannis D, Hanna H, Raad I. The utility of >100 CFU from the central venous catheter (CVC) in establishing the diagnosis of catheter-related bloodstream infection (CRBSI). 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
Youssef S, Hachem R, Chemaly R, Adachi J, Jacobson K, Jiang Y, Rolston K, Safdar A, Kontoyiannis D, Raad I. Vitamin B6 was not effective for the prevention of hematologic toxicities of linezolid (LNZ) in cancer patients (pts). Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of American, Toronto, Ontario, Canada, 2006. e-Pub 2006.
Shukrallah B, Ghannam D, Hackett B, Keutgen X, Jiang Y, Hachem R, Chemaly R, Kontoyiannis D, Hanna H, Raad I. The utility of >100 CFU from the central venous catheter (CVC) in establishing the diagnosis of catheter-related bloodstream infection (CRBSI. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of American. Toronto, Ontario, Canada, 2006. e-Pub 2006.
Ghanem G, Graviss L, Chemaly R, Hanna H, Dvorak T, Hulten K, Hachem R, Raad I. The role of molecular methods in the prevention of nosocomial methicillin resistant Staphylococcus aureus (MRSA) clusters in cancer patients. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of American. Toronto, Ontario, Canada, 2006. e-Pub 2006.
Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly R, Raad I. Comparative analysis of vancomycin resistant Enterococcus (VRE) faecalis vs VRE faeciumin cancer patients. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of American. Toronto, Ontario, Canada, 2006. e-Pub 2006.
Hachem R, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Raad I. Activity of rifampin against MRSA embedded in biofilm: the risk of resistance if used alone and benefit of synergy if used in combination. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, 2006. e-Pub 2006.
Reitzel R, Shukrallah B, Hanna H, Dvorak T, Hachem R, Raad I. Gloves impregnated with antiseptic dyes are highly effective in the prevention of adherence of nosocomial resistant bacteria. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, 2006. e-Pub 2006.
Raad I, Hanna H, Boktour M, Torres H, Afif C, Kontoyiannis D, Hachem R. Posaconazole (POS) compared to high dose lipid formulations of amphotericin B (HD-LPAMB) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). IN. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, 2006. e-Pub 2006.
Raad I, Hanna H, Boktour M, Torres H, Kontoyiannis D, Hachem R. The combination of caspofungin (C) and voriconazole (V) as primary and salvage therapy of invasive aspergillosis (IA) in hematologic malignancy patients (HMP). 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, 2006. e-Pub 2006.
Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Posaconazole (POS) compared to amphotericin B lipid formulations (AmB/LPD) in combination with caspofungin (CASP) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). 2nd Advances Against Apsergillosis, Athens, Greece, 2006. e-Pub 2006.
Boktour M, Hanna H, Kontoyiannis D, Hachem R, Raad I. Posaconazole (POS) compared to amphotericin B lipid formulations (AmB/LPD) in combination with itraconazole (IT) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM). 2nd Advances Against Apsergillosis, Athens, Greece, 2006. e-Pub 2006.
Hachem, RY, Boktour MR, Hanna HA, Torres H, Afif C, Kontoyiannis D, Raad II. Amphotericin B Lipid Complex (ABLC) vs Liposomal Amphotericin B (L-AMB) Monotherapy of Invasive Aspergillosis (IA) in Patients with Hematological Malignancy (HM). Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America [poster], San Francisco, CA, 2005. e-Pub 2005.
Hachem, RY, Chemaly RF, Ahmar C, Boktour M, Abou Rjaili G, Weiss LT, Bodey GP, Raad II. Does Colistin Have a Role in the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa (MDR-PSA) in Cancer Patients? . Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America [poster], San Francisco, CA,, 2005. e-Pub 2005.
Ansari, SR, Weiss LT, Hachem RY, Hanna HA, Safdar A, Boktour M, Rolston KV, Raad II. Role of prior antibiotic use in emergence of multidrug-resistant (MDR) Stenotrophomonas maltophilia in cancer patients. Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America [Abstract], San Francisco, California (accepted for presentation),, 2005. e-Pub 2005.
Aboufaycal, H, Adachi J, Hachem R, Weiss LT, Kontoyiannis DP, Safdar A, Chemaly R, Rolston K, Raad I. Risk factors and outcome of infection with multidrug-resistant (MDR) Escherichia coli in patients with cancer. Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America [Abstract], San Francisco, California (accepted for presentation),, 2005. e-Pub 2005.
Ghanem, GA, Boktour MR, Warneke C, Bahna BN, Kassis K, Chemaly RF, Hachem RY, Raad II. Catheter-related Staphylococcus aureus bacteremia (CRSAB) in cancer patients: high complication rate associated with type of malignancy. Proceedings of the 43rd Annual Meeting of the Infectious Diseases Society of America [Abstract], San Francisco, California, 2005. e-Pub 2005.
Bahna, BN, Hanna HA, Chemaly RF, Hachem RY, Raad II. Sources and Outcome of Bloodstream Infections (BSI) in Cancer Patients (pts): The Role of Quantitative Blood Cultures (QBC) and the Central Venous Catheter (CVC). . Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Hachem, RY, Hanna HA, Dvorak T, Kontoyiannis DP, Raad II. Antifungal activity of Amphotericin B Lipid Complex (ABLC) with EDTA Against Candida Embedded in Biofilm. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Hanna, H, Kontoyiannis D, Buddineni J, Boktour M, Antoniadou A, Hachem R, Raad I. The Changing Epidemiology of Candidemia in Hematologic Malignancy (HM): Candida krusei and Candida glabrata are the Leading Causes of Fungemia. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Hachem, R, Bahna P, Hanna H, Raad I. EDTA as an Adjunct Agent for the Treatment of Invasive Pulmonary Aspergillosis (IPA) in a Murine Model. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal Antimicrobial Catheter Lock Solution and Rapid Eradication of Organisms Embedded in Biofilm. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Hachem, RY, Hanna HA, Dvorak T, Chemaly RF, Raad II. Activity of Daptomycin and Tigecycline Against Clinical Isolates Causing Catheter-Related Methicillin-Resistant Staphylococcus aureus (CR-MRSA) Embedded in Biofilm. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Bahna, BN, Hanna HA, Dvorak T, Chaiban G, Chemaly RF, Hachem RY, Raad II. Gendine coated orthopedic metal devices (OMDs) for the prevention of bacterial infection. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,, 2005. e-Pub 2005.
Chemaly, RF, Torres HA, Rohtgi N, Kontyiannis DP, Sepulveda C, Hachem R, Raad II. Human herpesviruses-6 (HHV-6) viremia is associated with donor granulocyte transfusions (GTX) in heavily immunosuppressed patients (PTS) with leukemia. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (#V-592), New Orleans, LA,, 2005. e-Pub 2005.
Lee, LD, Berkheiser ML, Hackett B, Hachem R, Chemaly R, Raad I. The Risk of Bioaerosol Contamination with Aspergillus Species before and after Terminal Cleaning in Hepa-Filtered Rooms Housing Patients with Hematologic Malignancy (HM). Proceedings of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America [Abstract 84], Los Angeles, CA, , 2005. e-Pub 2005.
Aguilera, EA, Torres, HA, Gonzalez VR, Raad II, Hachem RY, Frenzel EC, Thomas GA, Chemaly RF. The Impact of Influenza Epidemic with a Predominant Mismatched Circulating Strain with the Vaccine Strain on Patients with Hematologic Malignancies. Proceedings of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America [Abstract 68], Los Angeles, CA,, 2005. e-Pub 2005.
Chemaly, RF, Gonzalez VR, Hachem RY, Perego CA, Donato ML, Champlin RE, Neumann JL, Johnston PA, Raad II. Detection and Control of a Nosocomial Respiratory Syncytial Virus (RSV) Outbreak in an Adult Bone Marrow Transplant Unit: the Role of Palivizumab. Proceedings of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America [Abstract 126], Los Angeles, CA,, 2005. e-Pub 2005.
Hachem, R, Lee LD, Berkheiser ML, Hackett B, Chemaly R, Perego, C, Kontoyiannis DP, Raad II. Nosocomial Invasive Aspergillosis (NIA) in Patients with Hematologic Maiognancy: is it Waterborne or Airborne? . Proceedings of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America [Abstract 70], Los Angeles, CA, , 2005. e-Pub 2005.
Chemaly, RF, Torres HA, Rohatgi N, Kontoyiannis DP, Safdar A, Kantarjian H, Daugherty T, Sepulveda C, Hachem R, Raad II. Human Herpesvirus-6 (HHV-6) Viremia is Assoicated with Donor Granulocyte Transfusions (gtx) in Heavily Immunosuppressed Patients (pts) with Leukemia. ). . The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract #], New Orleans, LA, 2005. e-Pub 2005.
Ansari, SR, Hanna HA, Hachem RY, Safdar A, Boktour M, Roslton KV, Raad II. Role of Prior Antibiotic Use in Emergence of Multidrug-Resistant (MDR) Stenotrophomonas maltophilia in Cancer Patients. [Abstract # ]. . The 43rd Annual Meeting of the Infectious Diseases Society of America (IDSA), San Francisco, CA, 2005. e-Pub 2005.
Hachem, R, Boktour M, Daugherty T, Pham-Williams T, Warneke C, Chemaly R, Raad I. The Utility of Galactomannan Enzyme Immunoassay (GM-EIA) and (1-3) B-D-glucan (BG) in the Diagnosis of Invasive Fungal Infections in Cancer Patients. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract ], New Orleans, LA,:September 21-24, 2005, 2005. e-Pub 2005.
Raad II, Hanna HA, Boktour M, Jabbour N, Hachem RY, Darouiche RO. Catheter-Related Vancomcyin-Resistant Enterococcus faecium Bacteremia: Clinical and Molecular Epidemiology. Proceedings of the 13th International Symposium on Infections in the Immunocompromised Host, Granada, Spain, 2004. e-Pub 2004.
Torres, HA, Younes A, Aguilera EA, Rodriguez GH, Luna MA, Tarrand J, Hachem RY, Raad II, Chemaly RF. Cytomegalovirus Pneumonia in Patients with Lymphoma. Proceedings of the 13th International Symposium on Infections in the Immunocompromised Host, Granada, Spain,, 2004. e-Pub 2004.
Raad I, Hachem R, Herbrecht R, Hare RS, Corcoran G. Experience of Posaconazole in Patients with Fusariosis. Proceedings of the 13th International Symposium on Infections in the Immunocompromised Host, Granada, Spain,, 2004. e-Pub 2004.
Hachem, R, Graybill JR, Negroni R, Schiller K, Zakowski P, Pedicone L. Posaconazole as salvage therapy for Pse infections: a case series. 14th Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, 2004. e-Pub 2004.
Raad I, Graviss L, Chemaly R, Hanna H, Hachem R, Hulten K, Kaplan S. The Perils of Molecular Typing: Does a Clonal Cluster of Nosocomial MRSA Always Imply Nosocomial Transmission?. Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy [Abstract K-70], Washington, DC,, 2004. e-Pub 2004.
Raad II, Hachem RY, Boktour MR, Chemaly RF, Daugherty TC, Hanna HA. Real Time PCR (RT-PCR) and Galactomannan (GM) for the Diagnosis of Invasive Aspergillosis (IA) in Cancer Patients. Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America [Abstract 620], Boston, MA,, 2004. e-Pub 2004.
Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Caspofungin (CASPO) Amphotericin B Lipid Formulations (AmB/LPD) or the Combination as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM). . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America [Abstract 678], Boston, MA,, 2004. e-Pub 2004.
Raad II, Boktour MR, Hanna HA, Kontoyiannis DP, Hachem RY. Posaconazole (POS) Compared to Amphotericin B Lipid Formulations (AmB/LPD) in Combination with Caspofungin (CASP) as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM) [Abstract M-1035]. Proceedings of the 44th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2, 2004, 2004. e-Pub 2004.
Raad I, Boktour M, Hanna H, Kontoyiannis D, Hachem R. Posaconazole (POS) Compared to Amphotericin B Lipid Formulations (AmB/LPD) alone or in Combination with Itraconazole (IT) as Salvage Therapy for Invasive Aspergillosis (IA) in Patients (pts) with Hematologic Malignancy (HM)[Abstract M-1035]. . Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2004. e-Pub 2004.
Hachem, RY, Hogan HH, Coyle EA, Neuhauser MM, Garey K, Raad II. The Safety and Toxicity of Linezolid in Bone Marrow Transplant Patients. Proceedings of the 45th Annual Meeting of the American Society of Hematology (abstract #1694), San Diego, California, 2003. e-Pub 2003.
Marr, K, Hachem R, Papanicolaou G, Somani J, Arduino JM, Lipka J, Ngai A, Chodakewitz J, Sable C. Retrospective Study of Concomitant Use of Caspofungin with Cyclosporin A (CsA) in Patients Treated During Marketed Use. Proceedings of the 45th Annual Meeting of the American Society of Hematology, San Diego, California, 2003. e-Pub 2003.
Girgawy, E, Hanna H, Graviss L, Chaiban G, Hachem R, Dvorak T, Chemaly R, Raad I. Chest tube (CT) related multidrug-resistant Staphylococcus aureus (MRSA) empyema: could the CT be coated with antiseptics? . Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America (abstract 389), San Diego, California,, 2003. e-Pub 2003.
Boktour, M, Hanna H, Kontoyiannis D, Hachem R, Girgawy E, Bodey G, Raad. Multiple species candidemia (MSC) in cancer patients: risk factors and response to antifungal therapy. Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America (abstract 391), San Diego, California,, 2003. e-Pub 2003.
Hachem, R, Graviss L, Arbuckle R, Hanna H, Dvorak T, Hackett B, Gonzalez V, Osting C, Tarrand J, Raad I. The impact of vancomcyin-resistant enterococcual (VRE) stool surveillance (SS) in patients with hematologic malignancy (HM) on controlling outbreak bacteremias. Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America (abstract 379), San Diego, California, , 2003. e-Pub 2003.
Hachem, R, Rice L, Hanna H, Dvorak T, Rolston K, Arbuckle R, Chaiban G, Raad I. Molecular patterns of decreased vancomcyin-resistant Enterococcus faecium (VREF) susceptibility for linezolid (LZD) associated with clinical use. Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America (abstract 216), San Diego, California,, 2003. e-Pub 2003.
Hanna, H, Chatzinikolaou I, Alakech B, Hachem R, Lewis R, Kontoyiannis D, Tarrand J, Raad I. Differential positive quantitative blood cultures (DPQBC) and the diagnosis of catheter-related bloodstream infections (CRBSI). Proceedings of the 41st Annual Meeting of the Infectious Diseases Society of America (abstract #334), San Diego, California, 2003. e-Pub 2003.
Raad II, Hachem RY, Hanna H, Rolston KVI. Myalgias/arthralgias (MA) occurring in patients receiving quinupristin/dalfopristin (QD) may be related to biliary dysfunction. Proceddings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (abstract A522), Chicago, Illinois,, 2003. e-Pub 2003.
Raad I, Hanna H, Chatzinikolaou I, Hachem R, Tarrand J. Is Clinical Response (CR) Following Catheter Removal Useful in Diagnosing Catheter-Related Bloodstream Infection (CRBSI)?. Proceedings of the 43rd Interscience Conference on Antimicrobials Agents and Chemotherapy (ICAAC)(abstract #K-137), Chicago, Illinois, , 2003. e-Pub 2003.
Ezzet, F, Wexler D, Courtney R, Martinho M, Cellary A, Huber C, Hachem R, Kontoyiannis D, Topelt K, Corcoran G, Conely OA, Raad I, Ullman AJ. Comparative bioavailability of orgal posaconazole (POS) in different dosage regimens: a population pharmacokinetic analysis. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (abstract #A1565), Chicago, Illinois,, 2003. e-Pub 2003.
Safdar, A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Raad II. Donor granulocyte transfusions in cancer patients with hematogenous candidiasis – Impact on fungemia outcome. Proceedings of the 43rd Interscience Conference on Antimicrobials Agents and Chemotherapy (ICAAC)(abstract M969), Chicago, Illinois,, 2003. e-Pub 2003.
Raad II, Chaiban G, Hanna HA, Dvorak T, Lewis R, Darouiche R, Hachem R. Activity of antibiotics against resistant gram positive organisms (RGPO) embedded in biofilm. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (abstract C-1118), Chicago, Illinois,, 2003. e-Pub 2003.
Ullmann, AJ, Cornely GA, Burchardt A, Huber C, Hachem R, Kontoyiannis DP, Topelt K, Lahey J, Ezzet F, Courtney R, Corcoran G, Raad I. Courtney R, Corcoran G, Raad I. Safety and efficacy of posaconazole (POS) in a pharmacokinetic study in patients with febrile neutropenia (FN) or refractory invasive fungal infection (rIFI). . Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (abstract #M-1257), Chicago, Illinois,, 2003. e-Pub 2003.
Chagua, MR, Hachem R, Raad I, Kontoyiannis D. Trichosporonosis in a Tertiary Care Cancer Center: Risk Factors, Spectrum and Determinants of Outcome. Proceedings of the 40th Annual Meeting of the Infectious Diseases Society of America (abstract #367), Chicago, Illinois,, 2002. e-Pub 2002.
Hachem, R, Kontoyiannis D, Boktour M, Afif C, Cooksley C, Chatzinikolaou I, Raad I. Invasive Aspergillosis (IA) with Aspergillus terreus (AT) and Aspergillus fumigatus (AF): A Comparative Analysis of Risk Factors and Outcome in Cancer Patients. Proceedings of the 40th Annual Meeting of the Infectious Diseases Society of America (abstract #338), Chicago, Illinois,, 2002. e-Pub 2002.
Hanna, H, Boktour M, Bodey G, Girgawy E, Kontoyiannis D, Hachem R, Raad I. Candida parapsillosis Fungemia (CPF) Responds Better to Antifungal Therapy than Fungemia Due to Candida albicans (CAF) in Immunocompromised Cancer Patients. Proceedings of the 40th Annual Meeting of the Infectious Diseases Society of America (abstract #349), Chicago, Illinois,, 2002. e-Pub 2002.
Kontoyiannis, D, Hanna H, Hachem R, Boktour M, Girgawy E, Mardani M, Bodey G, Raad I. Risk Factors of Poor Outcome of Fusariosis in a Tertiary Care Cancer Center. Proceedings of the 40th Annual Meeting of the Infectious Diseases Society of America (abstract #396), Chicago, Illinois, 2002. e-Pub 2002.
Hanna, H, Graviss L, Chaiban G, Dvorak T, Arbuckle R, Estey E, Munsell M, Hachem R, Champlin R, Raad I. Susceptibility patterns of Staphylococcus organisms in leukemia and bone marrow transplant (BMT) services after the use of minocycline/rifampin-impregnated central venous catheters (MR-CVCs) in a cancer hospital. . Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #K-74), San Diego, California, , 2002. e-Pub 2002.
Raad I, Hanna HA, Arbuckle RB, Chaiban G, Dvorak, Hachem RY. Susceptibility patterns of vancomycin-resistant enterococci (VRE) to quinupristin/dalfopristin (QD) and linezolid (LZD) before and after clinical use. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #E-1134), San Diego, California,, 2002. e-Pub 2002.
Kontoyiannis, DP, Hachem R, Lewis RE, Rivero G, Kantarjian H, Raad I. Efficacy and toxicity of the caspofungin/liposomal amphotericin B (CAS/LipoAMB) Combination in Documented or Possible Invasive Aspergillosis (IA) in Patients (Pts) with Hematologic Malignancies. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #M-1820), San Diego, California,, 2002. e-Pub 2002.
Raad I, Hanna H, Jabbour N, Boktour M, Dvorak T, Chaiban G, Hachem R. Molecular and clinical epidemiology of vancomycin-resistant enterococcal catheter-related bacteremia (VRE-CRI). Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #K-76), San Diego, California,, 2002. e-Pub 2002.
Hachem, R, Wright KC, Zermeno A, Bodey GP, Raad II. Safety and long-term durability of the silver iontophoretic catheter in an animal model. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #B-271), San Diego, California,, 2002. e-Pub 2002.
Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T. In vitro and ex vivo activity of minocycline and EDTA (M-EDTA) against microorganisms embedded in biofilm on catheters. Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract #K-75), San Diego, California, , 2002. e-Pub 2002.
Hicks, K, Hachem RY, Huen A, Raad II. Myelosuppression and serotonin syndrome associated with linezolid and selective serotonin re-uptake inhibitors (SSRIS). Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America (abstract no.) San Francisco, California,, 2001. e-Pub 2001.
Raad II, Escalante C, Hachem R, Hanna H, Afif C, Boktour M, Whimbey E, Kontoyiannis D, Jacobson K, Bodey G, Rolston K. Comparison between imipenem/cilastatin (I) and cefepime (C) as initial therapy for febrile neutropenic cancer patients (PTS) requiring hospitalization. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America (abstract no.) San Francisco, California,, 2001. e-Pub 2001.
Afif, C, Hanna HA, Alakech B, Boktour M, Tarrand J, Hachem R, Raad II. Central venous catheter-related gram negative bacteremia (CRGNB): significance of catheter removal in preventing relapse. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America (abstract no.) San Francisco, California,, 2001. e-Pub 2001.
Bodey, GP, Boktour M, May S, Duvic M, Girgawy E, Kontoyiannis D, Hachem R, Raad I. Cutaneous manifestation of Fusarium infections. Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America (abstract no.637) San Francisco, California,, 2001. e-Pub 2001.
Raad I, Tarrand J, Hanna H, Boktour M, Mardani M, Hachem R, Rolston K. Epidemiology, molecular mycology and environmental sources of Fusarium infection in cancer patients. Proceedings of the 11th Annual Meeting of the Society for Healthcare Epidemiology (abstract no. 209) Toronto, Ontario,:pp. 84, 2001. e-Pub 2001.
Kontoyiannis, DP, Vaziri I, Hanna H, Thornby J, Boktour M, Hachem R, Bodey GP, Raad II. Risk factors for Candida tropicalis fungemia in patients with cancer. Proceedings of the 40th Interscience conference on Antimicrobial Agents and Chemotherapy (ICAAC), pp. 360, Abstract #232, Toronto, Ontario, Canada,, 2000. e-Pub 2000.
Hanna, H, Alakech B, Chatzinikolaou I, Darouiche R, Rolston K, Whimbey E, Hachem R, Raad I. Predictors of catheter-related bloodstream Infections (CRBSI) in cancer patients with bacteremia or fungemia. Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America, pp. 112, Abstract #414, New Orleans, LA, , 2000. e-Pub 2000.
Hachem, RY, Raad II, Afif CM, Negroni R, Graybill J, Hadley S, Kantarjian H, Adams S, Mukwaya G. An open, non-comparative multicenter to evaluate efficacy and safety of posaconazole (SCH 56592) in the treatment of invasive fungal infections (IFI) refractory (R) to or intolerant (I) to standard therapy (ST). Proceedings of the 40th Interscience conference on Antimicrobial Agents and Chemotherapy (ICAAC), pp. 372, Abstract #1109, Toronto, Ontario, Canada,, 2000. e-Pub 2000.
Raad I, Huaringa A, Sumoza D, Hanna HA, Rolston KV, Kontoyiannis D, Hachem RY, Albitar M. Diagnosis of Invasive pulmonary aspergillosis (IPA) using polymerase chain reaction (PCR) based detection of Aspergillus in bronchoalveolar lavage (BAL). Proceedings of the 38th Annual Meeting of the Infectious Diseases Society of America, pp. 47, Abstract #40, New Orleans, LA,, 2000. e-Pub 2000.
Minari, AM, Hachem R, Raad I. Candida lusitaniae: An emerging cause of nosocomial breakthrough fungemia (BF) in cancer patients (pts). Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA,, 1999. e-Pub 1999.
Mardani, M Hanna HA, Hachem RY, Abbas J, Girgawy E, Raad II. Candida glabrata versus Candida albicans fungemia in immunocompromised patients (pts): a matched pair analysis. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA,, 1999. e-Pub 1999.
Hanna, H, Husni R, Hachem R, Raad I. Vancomycin-resistant Enterococcus faecium (VREF): Risk Factors for Infection in Colonized Cancer Patients. Proceedings of the 9th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), San Francisco, CA,, 1999. e-Pub 1999.
Hanna, H, Abbas J, Bodey G, Mardani M, Girgawy E, Abi-Said D, Hachem R, Raad I. Candida krusei Fungemia (CKF): An Escalating Serious Infection in Immunocompromised Patients (Pts). . Proceedings of the 9th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), San Francisco, CA,, 1999. e-Pub 1999.
Husni, R, Hachem R, Afif C, Raad I. Linezolid treatment for vancomycin-resistant Enterococcus (VRE) infections in cancer patients. Proceedings of the 37th Annual Meeting of the Infectious Disease Society of America (IDSA), Philadelphia, PA,, 1999. e-Pub 1999.
Hachem R, Raad II. Are bacitracin and gentamicin useful in combination for the eradication of vancomycin-resistant Enterococcus (VRE) fecal carriage?. Proceedings of the 38th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California,, 1998. e-Pub 1998.
Raad II, Hanna H, Richardson D, Abi-Said D, Awad A, Alrahwan A, Bivins C, Khan A, Mansour G, Hachem R. Optimal frequency of changing intravenous administration sets (IVAS): is it safe to prolong duration of use beyond 3 days (3D)?. Proceedings of the Eighth Annual Meeting of the Society for Healthcare Epidemiology of America, Orlando, Florida,, 1998. e-Pub 1998.
Raad I, Hanna H, Mendoza M, Hachem R, Alrahwan A, Abbas J, Umphrey J. Clonal outbreak of vancomycin-resistant Enterococcus faecium (VREF) in the Medical Intensive Care Unit (MICU) of a Cancer Center (CC). . Proceedings of the Eighth Annual Meeting of the Society for Healthcare Epidemiology of America, Orlando, Florida,, 1998. e-Pub 1998.
Raad I, Sumoza D, Huaringa A, Safar H, Hachem R, Dvorak T, Albitar M. Polymerase chain reaction (PCR) for the early diagnosis of invasive pulmonary aspergillosis (IPA) in cancer patients. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario,, 1997. e-Pub 1997.
Raad I, Darouiche R, Hachem R, Safar H, Darnule T, Abi-Said D, Mansouri M, Morck D. Effect of anti-infective coatings on biofilms. Proceedings of the Surfaces in Biomaterials; 96 Symposium. Chandler, AZ,, 1996. e-Pub 1996.
Raad I, Hachem R, Sherertz R. Efficacy of Minocycline/EDTA (M-EDTA) Flush in Preventing Catheter-related Bacteremia (CRB) and Septic Phlebitis (SP) in Rabbits. Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New Orleans, LA,, 1996. e-Pub 1996.
Raad I, Khan A, Abi-Said D, Whimbey E, Hachem R, Hill L. Intra-arterial Catheters For Cancer Chemotherapy (IACC): Low Infection Rate Associated with Aseptic Insertions. Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New Orleans, LA,, 1996. e-Pub 1996.
Raad I, Abi-Said D, Whimbey E, Rolston K, Hachem R, Bodey GP. Treatment of Febrile Neutropenic Cancer Patients: Carbapenem versus Monobactam Antibiotics. Proceedings of the Thirty-first Middle East Medical Assembly (MEMA), Beirut, Lebanon,, 1996. e-Pub 1996.
Raad II, Darouiche R, Abi-Said D, Harris R, Hachem R, Ericsson C. New Devices for the Prevention of Catheter-related Bacteremia. Proceedings of the Thirty-first Middle East Medical Assembly (MEMA), Beirut, Lebanon,, 1996. e-Pub 1996.
Raad I, Darouiche R, Hachem R. Central venous catheters (CVC) coated with minocycline and rifampin (M/R) for the prevention of catheter-related bacteremia (CRB). Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 1995. e-Pub 1995.
Raad I, Hachem R, Sherertz R. Minocycline-EDTA (M-EDTA) flush solution for the prevention of vascular catheter infection. . Proceedings of the Thirty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, FL, 1994. e-Pub 1994.
Raad I, Darouiche R, Hachem R, Bodey GP. The broad spectrum activity of catheters coated with minocycline and rifampin (M/R) against bacteria and fung. Proceedings of the Thirty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, FL,, 1994. e-Pub 1994.
Raad I, Sacilowski M, Hachem R, Bodey G. The activity of streptogramin RP59500 (RP) against methicillin sensitive and resistant Staphylococci. Proceedings of the Second International Conference on the Macrolides, Azolides and Streptogramins (ICMAS), Venice, Italy,, 1994. e-Pub 1994.
Raad I, Hachem R, Legha S, Bodey G. Novobiocin (Nov) and Rifampin (Rif): oral prophylactic antibiotics to prevent staphylococcal infections in patients receiving Interleukin-2 (IL2). . Thirty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, , 1993. e-Pub 1993.
Raad II, Hachem R, Darouiche R, Bodey G. Efficacy of minocycline/rifampin (M/R) in preventing staphylococcal infections: in vitro and in vivo correlation (Abstract No. 758). . Proceedings of the Thirty-third Interscience Conference on Antimicrobials Agents and Chemotherapy (ICAAC), New Orleans, LA, , 1993. e-Pub 1993.
Anaissie, E, Hachem R, Karyotakis N. Comparative activities of Fluconazole, Amphotericin B and D0870 against disseminated Trichosporon beigelii infection in mice. . Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA,, 1992. e-Pub 1992.
Anaissie, E, Hachem R, Bodey GP. A murine model of disseminated Candida krusei infection: low virulence, and efficacy of Amphotericin B and Fluconazole. Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA,, 1992. e-Pub 1992.
Anaissie, E, Gokaslan A, Hachem R, Stephens C. Disseminated trichosporonosis: Novel murine model, and experimental and clinical therapy. Programs and Abstracts of the American Society for Microbiology, 92nd General Meeting, New Orleans, LA,, 1992. e-Pub 1992.
Anaissie, E, Hachem R, Bodey G. Comparative activities of Fluconazole, Itraconazole, Saperconazole, SCH 39304 and Amphotericin B (AmB) against disseminated F. solani infection in mice. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia(Abstract No. 288):p. 134, 1990. e-Pub 1990.
Anaissie, E, Legrand C, Hachem R, Nelson P, Bodey G. Recovery of Fusarium spp. (Fus. Spp.) from the bloodstream using a rabbit model of systemic fusariosis (Syst. Fus.). Ninetieth Meeting of the American Society of Microbiology, Anaheim, California(Abstract No. F-28):p. 413, 1990. e-Pub 1990.
Anaissie, E, Espinel-Ingroff A, Kerkering T, Elting L, Karl C, Hachem R, Ho K, Vartivarian S, Bodey GP. Standardization of antifungal susceptibility testing using micro dilution technique. American Society for Microbiology (ASM) Annual Meeting, New Orleans, Louisiana,, 1989. e-Pub 1989.
Reuben, A, Anaissie E, Nelson P, Hachem R, Ho D. Susceptibility of Fusarium to Antifungals. American Society for Microbiology (ASM) Annual Meeting, New Orleans, Louisiana,, 1989. e-Pub 1989.
Anaissie, E, Hachem R, Vartivarian S, Elting L, Bodey GP. In Vivo/in vitro correlation of yeast susceptibility testing for Amphotericin B (AmB) and 5 Flucytosine (5FC). Twenty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas,, 1989. e-Pub 1989.
Anaissie, E, Hachem R, Rolston K, Bodey GP. New Spectrum of Fungal Infections in Patients with Cancer. Twenty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, CA,, 1988. e-Pub 1988.

Book Chapters

Hachem RY, Raad II. Infection of the salivary and lacrimal glands. In: Current Therapy of Infectious Disease, 2nd Edition. Mosby, Inc, pp. 27-31, 2001.

Patents

Raad I, Sherertz R, Hachem R. EDTA and Other Chelators With or Without Antifungal Antimicrobial Agents for the Prevention and Treatment of Fungal Infections. Patent Number: 09/680,061.
Raad I, Sherertz R, Hachem R. EDTA and Other Chelators With or Without Antifungal Antimicrobial Agents for the Prevention and Treatment of Fungal Infections. Patent Number: 09/139,522.

Less

CV information above last modified March 06, 2026

Ray Y. Hachem, M.D.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Honors & Awards

Professional Memberships

Selected Presentations & Talks

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patents

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Ray Y. Hachem, M.D.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Honors & Awards

Professional Memberships

Selected Presentations & Talks

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patents

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson